Skip to content

Contact +44 (0) 20 7060 7474 email us

Company Information

Global Pharmaceutical Companies

Find reports on companies involved in all aspects of the life-science industry.

Stay up-to-date with new products added to this category »
Title Publication Date Price
CareFusion Medical Device Company Intelligence Report
February 2010 £295
Hill-Rom Medical Device Company Intelligence Report
February 2010 £295
Medtronic Medical Device Company Intelligence Report
February 2010 £295
Dentsply International Inc.-Therapeutic Competitors
January 2010 £230
Eli Lilly: Pipeline, Products,Performance,Potential
January 2010 £595
Instituto Bioclon S.A. de C.V.-Company Report
January 2010 £495
Insect Biotech Co., Ltd-Company Report
January 2010 £495
Inotek Pharmaceuticals, Inc-Company Report
January 2010 £495
Intas Biopharmaceuticals Ltd.-Company Report
January 2010 £495
Intas Pharmaceuticals Ltd.-Company Report
January 2010 £495
Innopharmax, Inc.-Company Report
January 2010 £495
Intarcia Therapeutics, Inc.-Company Report
January 2010 £495
Inimex Pharmaceuticals Inc.-Company Report
January 2010 £495
Indoco Remedies Limited-Company Report
January 2010 £495
Indigene Pharmaceuticals, Inc.-Company Report
January 2010 £495
Indena S.p.A.-Company Report
January 2010 £495
Indukern Chemie AG-Company Report
January 2010 £495
Inflabloc Pharmaceuticals, Inc. (formerly Pharmadigm, Inc)-Company Report
January 2010 £495
Integrated BioTherapeutics, Inc.-Company Report
January 2010 £495
Infugen Pharma Pvt. Ltd.-Company Report
January 2010 £495
Innocoll Inc.-Company Report
January 2010 £495
InterMed Discovery GmbH-Company Report
January 2010 £495
ItherX, Inc.-Company Report
January 2010 £495
Italfarmaco S.p.A-Company Report
January 2010 £495
Istituto Ganassini-Company Report
January 2010 £495
Izun Pharma Ltd-Company Report
January 2010 £495
J.B.CHEMICALS & PHARMACEUTICALS LIMITED-Company Report
January 2010 £495
JINIS Biotechnology Corporation-Company Report
January 2010 £495
JCR Pharmaceuticals Co., Ltd-Company Report
January 2010 £495
JADO Technologies GmbH-Company Report
January 2010 £495
Ipsat Therapies Oy-Company Report
January 2010 £495
Ipca Laboratories Limited-Company Report
January 2010 £495
Intercept Pharmaceuticals, Inc.-Company Report
January 2010 £495
Intercell AG-Company Report
January 2010 £495
Ind-Swift Limited-Company Report
January 2010 £495
Intercytex-Company Report
January 2010 £495
Intra Labs Pvt. Ltd.-Company Report
January 2010 £495
Inviragen, Inc.-Company Report
January 2010 £495
Intra-Cellular Therapies, Inc. (ITI)-Company Report
January 2010 £495
Intendis GmBH-Company Report
January 2010 £495
InDex Pharmaceuticals AB-Company Report
January 2010 £495
Hope Pharmaceutical Inc.-Company Report
January 2010 £495
Hoe Pharmaceuticals Sdn. Bhd.-Company Report
January 2010 £495
Histogen, Inc.-Company Report
January 2010 £495
Hovid Bhd-Company Report
January 2010 £495
Humanetics Corporation-Company Report
January 2010 £495
Hybrigenics-Company Report
January 2010 £495
Hy BioPharma Inc.-Company Report
January 2010 £495
Hutchison China MediTech, Ltd-Company Report
January 2010 £495
Hisamitsu Pharmaceutical Co., Inc.-Company Report
January 2010 £495
Hikma Pharmaceuticals PLC-Company Report
January 2010 £495
Helix BioPharma Corp.-Company Report
January 2010 £495
Heidelberg Pharma AG-Company Report
January 2010 £495
Hebron-Company Report
January 2010 £495
Henan Topfond Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Heritage Pharmaceuticals Inc.-Company Report
January 2010 £495
Highnoon Laboratories Ltd.-Company Report
January 2010 £495
Hetero drugs Ltd.-Company Report
January 2010 £495
Hydra Biosciences, Inc.-Company Report
January 2010 £495
Hyperion Therapeutics, Inc.-Company Report
January 2010 £495
Immunotec Inc.-Company Report
January 2010 £495
ImmuPharma plc-Company Report
January 2010 £495
ImQuest Life Sciences-Company Report
January 2010 £495
Immunotope, Inc.-Company Report
January 2010 £495
Immuron (formerly Anadis, Ltd.)-Company Report
January 2010 £495
JN International Medical Corporation-Company Report
January 2010 £495
Immutep S.A.-Company Report
January 2010 £495
ImClone Systems Incorporated-Company Report
January 2010 £495
Il-Yang Pharm.-Company Report
January 2010 £495
IDEA AG-Company Report
January 2010 £495
IBSA Institut Biochimique SA-Company Report
January 2010 £495
Hyundai Pharm. CO., LTD.-Company Report
January 2010 £495
IRX Therapeutics, Inc.-Company Report
January 2010 £495
IS Pharma plc (formerly Maelor Pharmaceuticals Ltd.)-Company Report
January 2010 £495
ISU ABXIS Inc. (formerly PetaGen)-Company Report
January 2010 £495
ISDIN-Company Report
January 2010 £495
Incitive Ltd-Company Report
January 2010 £495
JSC Grindeks-Company Report
January 2010 £495
Kuhnil Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Krka, d. d.-Company Report
January 2010 £495
Krenitsky Pharmaceuticals Inc.-Company Report
January 2010 £495
KunWha Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Kureha Corporation (formerly Kureha Chemical Industry Co., Ltd.)-Company Report
January 2010 £495
Kwizda Pharma GmbH-Company Report
January 2010 £495
Kwang-Dong Pharmaceutical Co., Ltd-Company Report
January 2010 £495
Kuros Biosurgery AG-Company Report
January 2010 £495
Kowa Company, Ltd.-Company Report
January 2010 £495
Korea Vaccine Co., Ltd.-Company Report
January 2010 £495
Kissei Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Kinex Pharmaceuticals, LLC-Company Report
January 2010 £495
Kilitch Drugs (India) Ltd.-Company Report
January 2010 £495
Kitasato Institute Research Center for Biologicals-Company Report
January 2010 £495
Kobayashi Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Kopran Ltd.-Company Report
January 2010 £495
Kontest Chemicals Limited-Company Report
January 2010 £495
Kyorin Co., Ltd.-Company Report
January 2010 £495
Kyosei Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Cytochroma Inc.-Company Report
January 2010 £495
CytoTools AG-Company Report
January 2010 £495
CytImmune Sciences, Inc.-Company Report
January 2010 £495
Cytokine PharmaSciences Inc.-Company Report
January 2010 £495
Cytopia Ltd.-Company Report
January 2010 £495
DAVA Pharmaceuticals, Inc.-Company Report
January 2010 £495
D-Pharm Ltd-Company Report
January 2010 £495
iNova Pharmaceuticals (Australia) Pty Limited-Company Report
January 2010 £495
hameln group gmbh-Company Report
January 2010 £495
Kythera Biopharmaceuticals, Inc.-Company Report
January 2010 £495
Kyowa Hakko Kirin Co., Ltd. (formerly Kyowa Hakko Kogyo Co., Ltd.)-Company Report
January 2010 £495
Kyoto Pharmaceutical Industries-Company Report
January 2010 £495
Kyung Dong Pharma. Co., Ltd.-Company Report
January 2010 £495
Labima-Company Report
January 2010 £495
Laboratoire Innotech International-Company Report
January 2010 £495
Laborate Pharmaceuticals India Ltd-Company Report
January 2010 £495
Kiadis Pharma B.V.-Company Report
January 2010 £495
KeyNeurotek AG-Company Report
January 2010 £495
Jerini AG-Company Report
January 2010 £495
Jennerex Biotherapeutics, Inc.-Company Report
January 2010 £495
Jenburkt Pharmaceuticals Ltd.-Company Report
January 2010 £495
Jiangsu Hengrui Medicine Co., Ltd.-Company Report
January 2010 £495
Jiangsu Lianshui Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Juste S.A.Q.F.-Company Report
January 2010 £495
Jiwa Bio-Pharm Holdings Limited-Company Report
January 2010 £495
Jin Yang Pharmaceutical Co. Ltd-Company Report
January 2010 £495
Jemo-pharm A/S-Company Report
January 2010 £495
Jelfa Pharmaceutical Company SA-Company Report
January 2010 £495
Jagsonpal Pharmaceuticals Limited-Company Report
January 2010 £495
Jadran Galenski laboratorij d.d. (JGL)-Company Report
January 2010 £495
Healthpoint, Ltd.-Company Report
January 2010 £495
Janssen Pharmaceutica N.V.-Company Report
January 2010 £495
Janssen-Cilag S.p.A.-Company Report
January 2010 £495
Jeil Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Japan Tobacco Inc.-Company Report
January 2010 £495
KAI Pharmaceuticals Inc.-Company Report
January 2010 £495
KAKEN PHARMACEUTICAL CO., LTD.-Company Report
January 2010 £495
Kedrion S.p.A-Company Report
January 2010 £495
Karo Bio AB-Company Report
January 2010 £495
Kamron Laboratories Ltd.-Company Report
January 2010 £495
Kee Pharma Ltd.-Company Report
January 2010 £495
Kemin Industries, Inc.-Company Report
January 2010 £495
Kereos, Inc-Company Report
January 2010 £495
Kenta Biotech Ltd.-Company Report
January 2010 £495
Kamada Ltd.-Company Report
January 2010 £495
Kalypsys, Inc.-Company Report
January 2010 £495
KIPA Pharmacal Ltd-Company Report
January 2010 £495
KARNATAKA ANTIBIOTICS AND PHARMACEUTICALS LIMITED-Company Report
January 2010 £495
KAKETSUKEN-Company Report
January 2010 £495
KOBEC Pharmacals-Company Report
January 2010 £495
KUKJE PHARMA IND CO LTD-Company Report
January 2010 £495
KaloBios Pharmaceuticals, Inc.-Company Report
January 2010 £495
Kaire International (Canada) Ltd-Company Report
January 2010 £495
JSC Farmak International-Company Report
January 2010 £495
Hawon Pharmaceutical Corporation-Company Report
January 2010 £495
Microlabs Ltd.-Company Report
January 2010 £495
MicroBiotiX, Inc-Company Report
January 2010 £495
Meyer Pharmaceuticals, LLC-Company Report
January 2010 £495
Mikasa Seiyaku Co., Ltd.-Company Report
January 2010 £495
Milan Laboratories (India) Private Limited-Company Report
January 2010 £495
Minapharm Pharmaceuticals-Company Report
January 2010 £495
Mimetica-Company Report
January 2010 £495
Millennium Pharmaceuticals, Inc.-Company Report
January 2010 £495
Metabolic Solutions Development Co.-Company Report
January 2010 £495
Metabolex, Inc.-Company Report
January 2010 £495
Merckle Group-Company Report
January 2010 £495
Merck Serono S.A.-Company Report
January 2010 £495
Merck KGaA-Company Report
January 2010 £495
Merrimack Pharmaceuticals, Inc.-Company Report
January 2010 £495
Merrion Pharmaceuticals, Ltd.-Company Report
January 2010 £495
Mesoblast Limited-Company Report
January 2010 £495
Merz Pharma GmbH & Co. KGaA-Company Report
January 2010 £495
Minerva Pharmaceutical S.A.-Company Report
January 2010 £495
Mipharm SpA-Company Report
January 2010 £495
Morepen Laboratories Limited-Company Report
January 2010 £495
Moraceae Pharmaceuticals Pvt Ltd.-Company Report
January 2010 £495
MonoSol RX-Company Report
January 2010 £495
MorphoSys AG-Company Report
January 2010 £495
Morria Biopharmaceuticals Plc.-Company Report
January 2010 £495
Mundipharma K.K.-Company Report
January 2010 £495
Mundipharma International Limited-Company Report
January 2010 £495
Molteni Farmaceutici-Company Report
January 2010 £495
Molteni Dental-Company Report
January 2010 £495
Mitsubishi Tanabe Pharma Corporation-Company Report
January 2010 £495
Mission Pharmacal Company-Company Report
January 2010 £495
Mirna Therapeutics Inc.-Company Report
January 2010 £495
Moberg Derma AB-Company Report
January 2010 £495
Mochida Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Molecular Design International (MDI)-Company Report
January 2010 £495
MolMed S.p.A.-Company Report
January 2010 £495
Merck Frosst Canada Ltd.-Company Report
January 2010 £495
Mercian Corporation-Company Report
January 2010 £495
Medek Ltd-Company Report
January 2010 £495
Meda AB-Company Report
January 2010 £495
MedExGen Inc.-Company Report
January 2010 £495
Medestea Internazionale S.p.A.-Company Report
January 2010 £495
MediGene AG-Company Report
January 2010 £495
Medico Remedies Pvt. Ltd.-Company Report
January 2010 £495
Medico Labs Inc-Company Report
January 2010 £495
MediQuest Therapeutics, Inc.-Company Report
January 2010 £495
Mebiopharm Co., Ltd.-Company Report
January 2010 £495
May & Baker Nigeria Plc-Company Report
January 2010 £495
Marillion Pharmaceuticals, Inc-Company Report
January 2010 £495
Mapra Laboratories Pvt. Ltd.-Company Report
January 2010 £495
Maneesh Pharmaceuticals Private Ltd-Company Report
January 2010 £495
MarinEx Pharmaceuticals Pte Ltd-Company Report
January 2010 £495
Maruho Co., Ltd.-Company Report
January 2010 £495
MaxoCore Pharmaceuticals Inc-Company Report
January 2010 £495
Maruishi Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Medigen Biotechnology Corp.-Company Report
January 2010 £495
Mediline Ltd.-Company Report
January 2010 £495
Memgen, LLC-Company Report
January 2010 £495
Melior Discovery, Inc.-Company Report
January 2010 £495
Meiji Seika Kaisha, Ltd.-Company Report
January 2010 £495
Menarini Group-Company Report
January 2010 £495
Mentor Corporation-Company Report
January 2010 £495
MerLion Pharmaceuticals Pte. Ltd-Company Report
January 2010 £495
Mepha AG-Company Report
January 2010 £495
Medreich Plc-Company Report
January 2010 £495
Medopharm-Company Report
January 2010 £495
Medinox, Inc.-Company Report
January 2010 £495
Medinova AG-Company Report
January 2010 £495
Medimport S.A. de C.V-Company Report
January 2010 £495
Mediolanum farmaceutici S.p.A-Company Report
January 2010 £495
Medison Pharma Ltd.-Company Report
January 2010 £495
Medivir AB-Company Report
January 2010 £495
Medisyn Technologies, Inc.-Company Report
January 2010 £495
Mutabilis-Company Report
January 2010 £495
MycoLogics, Inc-Company Report
January 2010 £495
GlycoMimetics, Inc.-Company Report
January 2010 £495
Gloucester Pharmaceuticals-Company Report
January 2010 £495
GlobeImmune, Inc.-Company Report
January 2010 £495
Glycotex, Inc.-Company Report
January 2010 £495
Goldshield Group plc-Company Report
January 2010 £495
Grifols, S.A.-Company Report
January 2010 £495
Green Cross Corporation-Company Report
January 2010 £495
Graceway Pharmaceuticals, LLC-Company Report
January 2010 £495
Glenwood, LLC-Company Report
January 2010 £495
GRUPO URIACH-Company Report
January 2010 £495
multimmune GmbH-Company Report
January 2010 £495
mondoBIOTECH group-Company Report
January 2010 £495
moksha8 Pharmaceuticals, Inc.-Company Report
January 2010 £495
neuMirRx Corporation-Company Report
January 2010 £495
GLYCOTOPE GmbH-Company Report
January 2010 £495
GP Pharm-Company Report
January 2010 £495
GNI Ltd.-Company Report
January 2010 £495
Grunenthal GmbH-Company Report
January 2010 £495
Grupo Ferrer-Company Report
January 2010 £495
Hansa Medical AB-Company Report
January 2010 £495
Hanmi Pharmaceutical Company Limited-Company Report
January 2010 £495
Hangzhou Jiuyuan Gene Engineering Co. Ltd-Company Report
January 2010 £495
Hawaii Biotech, Inc.-Company Report
January 2010 £495
DAWA Limited-Company Report
January 2010 £495
Hayashibara Co., Ltd.-Company Report
January 2010 £495
Hawthorn Pharmaceuticals, Inc.-Company Report
January 2010 £495
Handok Pharmaceuticals Co., Ltd.-Company Report
January 2010 £495
HanAll Pharmaceutical-Company Report
January 2010 £495
HELSINN HEALTHCARE SA-Company Report
January 2010 £495
H-Phar SA-Company Report
January 2010 £495
Gufic BioSciences Ltd.-Company Report
January 2010 £495
HERMES Biosciences-Company Report
January 2010 £495
HOMEOFARM Sp. z o.o.-Company Report
January 2010 £495
Hamilton Laboratories-Company Report
January 2010 £495
HRA Pharma-Company Report
January 2010 £495
medac GmbH-Company Report
January 2010 £495
NextWave Pharmaceuticals-Company Report
January 2010 £495
NatImmune A/S-Company Report
January 2010 £495
Narhex Life Sciences Ltd-Company Report
January 2010 £495
Napp Pharmaceuticals Limited-Company Report
January 2010 £495
Natural F&P. Inc-Company Report
January 2010 £495
Navamedic ASA-Company Report
January 2010 £495
Nectar Lifesciences Ltd.-Company Report
January 2010 £495
Navana Pharmaceuticals Ltd.-Company Report
January 2010 £495
Napo Pharmaceuticals Inc.-Company Report
January 2010 £495
Nanotherapeutics, Inc.-Company Report
January 2010 £495
NATCO PHARMA LIMITED-Company Report
January 2010 £495
MyungMoon Pharm Co. Ltd-Company Report
January 2010 £495
Mystic Pharmaceuticals, Inc.-Company Report
January 2010 £495
NERVIANO MEDICAL SCIENCES S.r.l.-Company Report
January 2010 £495
Nanjing Lifenergy R&D Co., Ltd.-Company Report
January 2010 £495
NanoDel Technologies GmbH-Company Report
January 2010 £495
NanoBio Corporation-Company Report
January 2010 £495
Neon Laboratories Ltd.-Company Report
January 2010 £495
Neopharma-Company Report
January 2010 £495
Neuropharm Group plc-Company Report
January 2010 £495
Neuromed Pharmaceuticals Ltd. (formerly NeuroMed Technologies)-Company Report
January 2010 £495
NeuroSearch A/S-Company Report
January 2010 £495
Neurotech Pharmaceuticals-Company Report
January 2010 £495
NewLink Genetics Corporation-Company Report
January 2010 £495
NexGenix Pharmaceuticals Holdings, Inc.-Company Report
January 2010 £495
Newron Pharmaceuticals SpA-Company Report
January 2010 £495
NeuroNova AB-Company Report
January 2010 £495
NeuroDiscovery Ltd-Company Report
January 2010 £495
Nephron Pharmaceuticals Corporation-Company Report
January 2010 £495
Neovacs SA-Company Report
January 2010 £495
Neotropix, Inc.-Company Report
January 2010 £495
Nereus Pharmaceuticals, Inc.-Company Report
January 2010 £495
NeurAxon, Inc.-Company Report
January 2010 £495
Neurim Pharmaceuticals Ltd.-Company Report
January 2010 £495
Neuren Pharmaceuticals Limited-Company Report
January 2010 £495
Hayat Pharmaceutical Industries (HPI)-Company Report
January 2010 £495
DMI BioSciences, Inc.-Company Report
January 2010 £495
Bio-Pharm, Inc.-Company Report
January 2010 £495
Bilim Pharmaceuticals-Company Report
January 2010 £495
BiPar Sciences, Inc.-Company Report
January 2010 £495
BioAlliance Pharma-Company Report
January 2010 £495
BioCancell Therapeutics, Inc.-Company Report
January 2010 £495
BioNumerik Pharmaceuticals, Inc.-Company Report
January 2010 £495
BioLineRx, Ltd.-Company Report
January 2010 £495
BioInvent International AB-Company Report
January 2010 £495
BiOrion Technologies BV-Company Report
January 2010 £495
Bharat Serums And Vaccines Limited-Company Report
January 2010 £495
Benesis Corporation-Company Report
January 2010 £495
Belupo-Company Report
January 2010 £495
Beijing Zizhu Pharmaceutical Co.,Ltd-Company Report
January 2010 £495
Besins Healthcare SA-Company Report
January 2010 £495
BestoChem Formulations (I) Ltd-Company Report
January 2010 £495
Bharat Biotech International Limited-Company Report
January 2010 £495
Beximco Pharmaceuticals Ltd.-Company Report
January 2010 £495
BioPartners GmbH-Company Report
January 2010 £495
BioPhausia AB-Company Report
January 2010 £495
Biomedica International-Company Report
January 2010 £495
Biological E. Ltd.-Company Report
January 2010 £495
Biolex Therapeutics-Company Report
January 2010 £495
Biomedica foscama-Company Report
January 2010 £495
Biomet Europe B.V.-Company Report
January 2010 £495
Bionor Immuno AS-Company Report
January 2010 £495
Bionomics Limited-Company Report
January 2010 £495
Biolab Farmaceutica-Company Report
January 2010 £495
Biofrontera AG-Company Report
January 2010 £495
BioXell S.p.A.-Company Report
January 2010 £495
BioVex Inc-Company Report
January 2010 £495
BioPro Pharmaceutical, Inc.-Company Report
January 2010 £495
Biocad-Company Report
January 2010 £495
Biochefa-Company Report
January 2010 £495
Biofarma Pharmaceutical Industry Co. Inc.-Company Report
January 2010 £495
Biocompatibles International plc-Company Report
January 2010 £495
Beijing SL Pharmaceutical Co., Ltd-Company Report
January 2010 £495
Bedford Laboratories-Company Report
January 2010 £495
Germiphene Corporation-Company Report
January 2010 £495
Georen Pharmaceuticals (Pty) Ltd.-Company Report
January 2010 £495
Genovate Biotechnology Co., Ltd. (GBL)-Company Report
January 2010 £495
Gerolymatos-Company Report
January 2010 £495
Gerot Pharmazeutika-Company Report
January 2010 £495
Glades Pharmaceuticals LLC.-Company Report
January 2010 £495
Giuliani S.p.A-Company Report
January 2010 £495
Giaconda Limited-Company Report
January 2010 £495
Geno Pharmaceuticals Ltd.-Company Report
January 2010 £495
Genmab A/S-Company Report
January 2010 £495
Genesis Research & Development Corporation Limited-Company Report
January 2010 £495
Generics (UK) Limited-Company Report
January 2010 £495
General Pharmaceuticals Ltd.-Company Report
January 2010 £495
Genetix Pharmaceuticals, Inc.-Company Report
January 2010 £495
Genexine Co., Ltd.-Company Report
January 2010 £495
Genfit-Company Report
January 2010 £495
Genextra S.p.A.-Company Report
January 2010 £495
Gland Pharma Limited-Company Report
January 2010 £495
Glenmark Pharmaceuticals Limited-Company Report
January 2010 £495
BOUTY-Company Report
January 2010 £495
BLIS Technologies Ltd-Company Report
January 2010 £495
BL&H Co., Ltd.-Company Report
January 2010 £495
BTG plc-Company Report
January 2010 £495
Beacon Pharmaceuticals Ltd-Company Report
January 2010 £495
Beckpharma Ltd.-Company Report
January 2010 £495
Beacons Pharmaceuticals Pte Ltd-Company Report
January 2010 £495
BIOTON S.A-Company Report
January 2010 £495
BIOMED Wytwornia Surowic i Szczepionek Sp. z o.o.-Company Report
January 2010 £495
BELCO PHARMA-Company Report
January 2010 £495
ATCO Laboratories Limited-Company Report
January 2010 £495
e-Therapeutics-Company Report
January 2010 £495
BETA DERMACEUTICALS, INC.-Company Report
January 2010 £495
BINEX Co., Ltd-Company Report
January 2010 £495
BIOFARM Sp. z o.o.-Company Report
January 2010 £495
BIOCODEX-Company Report
January 2010 £495
BiopolyMed Inc.-Company Report
January 2010 £495
Biosyntrx, Inc.-Company Report
January 2010 £495
Cangene Corporation-Company Report
January 2010 £495
Canderm Pharma Inc.-Company Report
January 2010 £495
Cancer Research Technology Ltd.-Company Report
January 2010 £495
Cannasat Therapeutics Inc.-Company Report
January 2010 £495
Canopus BioPharma, Inc.-Company Report
January 2010 £495
Cara Therapeutics Inc-Company Report
January 2010 £495
Capricorn Pharma, Inc.-Company Report
January 2010 £495
Capellon Pharmaceuticals, Ltd.-Company Report
January 2010 £495
CanBas Co., Ltd.-Company Report
January 2010 £495
Can-Fite BioPharma, Ltd.-Company Report
January 2010 £495
CSL Limited-Company Report
January 2010 £495
CSC Pharmaceuticals Handels GmbH-Company Report
January 2010 £495
CORIA Laboratories, Ltd.-Company Report
January 2010 £495
Cachet Pharmaceuticals Pvt. Ltd.-Company Report
January 2010 £495
Calando Pharmaceuticals, Inc-Company Report
January 2010 £495
Camurus AB-Company Report
January 2010 £495
Cambridge Laboratories-Company Report
January 2010 £495
Cardax Pharmaceuticals, Inc.-Company Report
January 2010 £495
Cellerant Therapeutics, Inc.-Company Report
January 2010 £495
Changzhou Siyao Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Changchun ChangSheng Gene Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Chakshu Research-Company Report
January 2010 £495
Charlesson LLC-Company Report
January 2010 £495
ChemoCentryx, Inc.-Company Report
January 2010 £495
Chiesi Farmaceutici S.p.A-Company Report
January 2010 £495
Chenho Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Cerep-Company Report
January 2010 £495
Ceregene, Inc-Company Report
January 2010 £495
Celon Pharma-Company Report
January 2010 £495
Cellzome AG-Company Report
January 2010 £495
Celltran Limited-Company Report
January 2010 £495
Cempra Pharmaceuticals, Inc.-Company Report
January 2010 £495
Cenomed BioSciences, LLC-Company Report
January 2010 £495
Centrix Pharmaceutical, Inc.-Company Report
January 2010 £495
Centaur Pharmaceuticals Pvt. Ltd.-Company Report
January 2010 £495
COOPER PHARMA-Company Report
January 2010 £495
CLL PHARMA-Company Report
January 2010 £495
Blue Note Pharmaceuticals, BV-Company Report
January 2010 £495
Blue Cross Laboratories, Ltd.-Company Report
January 2010 £495
Blairex Laboratories, Inc.-Company Report
January 2010 £495
Boca Pharmacal, Inc.-Company Report
January 2010 £495
Boehringer Ingelheim GmbH-Company Report
January 2010 £495
Bolder BioTechnology, Inc.-Company Report
January 2010 £495
Bohus BioTech AB-Company Report
January 2010 £495
Blaine Pharmaceuticals-Company Report
January 2010 £495
Biovitrum AB-Company Report
January 2010 £495
Biotest AG-Company Report
January 2010 £495
Biotec Pharmacon ASA-Company Report
January 2010 £495
Biota Holdings Limited-Company Report
January 2010 £495
Biothera.-Company Report
January 2010 £495
Biotherapix SLU-Company Report
January 2010 £495
Biotron Limited-Company Report
January 2010 £495
Biotie Therapies Corp.-Company Report
January 2010 £495
Bone Medical Ltd-Company Report
January 2010 £495
Boram Pharm. Co., Ltd.-Company Report
January 2010 £495
C&O Pharmaceutical Technology (Holdings) Limited-Company Report
January 2010 £495
BurnsAdler Pharmaceuticals, Inc.-Company Report
January 2010 £495
Bukwang Pharmaceutical Company Limited-Company Report
January 2010 £495
CBio Limited-Company Report
January 2010 £495
CCL Pharmaceuticals-Company Report
January 2010 £495
CJ Corp.-Company Report
January 2010 £495
CHO-A Pharmaceutical Company-Company Report
January 2010 £495
Brookes Pharmaceutical Laboratories (Pakistan) Limited-Company Report
January 2010 £495
British Biologicals-Company Report
January 2010 £495
Braintree Laboratories Inc.-Company Report
January 2010 £495
Bosnalijek d.d.-Company Report
January 2010 £495
Boryung Pharmaceutical Company, Ltd.-Company Report
January 2010 £495
Bravo Healthcare Ltd.-Company Report
January 2010 £495
Breckenridge Pharmaceutical, Inc.-Company Report
January 2010 £495
Britannia Pharmaceuticals Limited-Company Report
January 2010 £495
Bridge BioResearch plc-Company Report
January 2010 £495
GeneraMedix Inc.-Company Report
January 2010 £495
GeneScience Pharmaceuticals Co., Ltd-Company Report
January 2010 £495
EKR Therapeutics, Inc.-Company Report
January 2010 £495
EGIS Pharmaceuticals PLC-Company Report
January 2010 £495
ECR Pharmaceuticals-Company Report
January 2010 £495
ELPEN Pharmaceutical Co. Inc.-Company Report
January 2010 £495
ELSaad Pharmaceutical Industries-Company Report
January 2010 £495
EOS S.p.A.-Company Report
January 2010 £495
ENT Technologies PTY LTD-Company Report
January 2010 £495
EMZOR Pharmaceuticals Ltd.-Company Report
January 2010 £495
EBEWE Pharma Ges.m.b.H. Nfg.KG-Company Report
January 2010 £495
Dynogen Pharmaceuticals, Inc.-Company Report
January 2010 £495
Drogsan Pharmaceuticals-Company Report
January 2010 £495
Dr. Kade Pharmazeutische Fabrik GmbH-Company Report
January 2010 £495
Dr. Fischer SA / NV-Company Report
January 2010 £495
Drug Houses of Australia (Asia) Pte. Ltd.-Company Report
January 2010 £495
Drugfield Pharmaceuticals Ltd.-Company Report
January 2010 £495
Dynapharm (M) Sdn. Bhd.-Company Report
January 2010 £495
DynPort Vaccine Company LLC-Company Report
January 2010 £495
ERYtech Pharma-Company Report
January 2010 £495
ESBATech AG-Company Report
January 2010 £495
Embil Pharmaceutical Co. Ltd.-Company Report
January 2010 £495
Elixir Pharmaceuticals, Inc.-Company Report
January 2010 £495
Elite Pharma Pvt. Ltd.-Company Report
January 2010 £495
Emcure Pharmaceuticals Ltd.-Company Report
January 2010 £495
EnVivo Pharmaceuticals-Company Report
January 2010 £495
Endocyte, Inc.-Company Report
January 2010 £495
Enanta Pharmaceuticals, Inc.-Company Report
January 2010 £495
Elder Pharmaceuticals Ltd-Company Report
January 2010 £495
EirGen Pharma Ltd.-Company Report
January 2010 £495
EastPharma, Ltd.-Company Report
January 2010 £495
East India Pharmaceutical Works Limited-Company Report
January 2010 £495
ESPEFA-Company Report
January 2010 £495
Ebiotec-Company Report
January 2010 £495
Efroze Chemical Industries (Pvt.) Ltd-Company Report
January 2010 £495
Egyptian Co. for Chemicals & Pharmaceuticals S.A.E. (ADWIA)-Company Report
January 2010 £495
Egalet a/s-Company Report
January 2010 £495
Dr. Falk Pharma GmbH-Company Report
January 2010 £495
Dong-A Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Daiichi Sankyo Company, Limited-Company Report
January 2010 £495
Daihan Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Dafra Pharma nv-Company Report
January 2010 £495
Dainippon Sumitomo Pharma Co., Ltd.-Company Report
January 2010 £495
Dawnrays Pharmaceutical (Holdings) Ltd.-Company Report
January 2010 £495
Deciphera Pharmaceuticals, LLC-Company Report
January 2010 £495
Debiopharm Group-Company Report
January 2010 £495
DaySpring Pharma-Company Report
January 2010 £495
Daewoong Pharmaceutical Co. Ltd.-Company Report
January 2010 £495
Daewon Pharm. Co., Ltd.-Company Report
January 2010 £495
DNAVEC Corporation-Company Report
January 2010 £495
Mallinckrodt Inc.-Company Report
January 2010 £495
DHG Pharmaceutical Joint Stock Company (formerly Hau Giang Pharmaceutical Joint Stock Company)-Company Report
January 2010 £495
DOMAIN Therapeutics (formerly Faust Pharmaceuticals)-Company Report
January 2010 £495
DONG WHA PHARM. IND. CO., LTD.-Company Report
January 2010 £495
Daehwa Pharm Co., Ltd.-Company Report
January 2010 £495
DONGKOOK Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Del Laboratories, Inc.-Company Report
January 2010 £495
Depsons Pharma-Company Report
January 2010 £495
Digna Biotech, S.L.-Company Report
January 2010 £495
Difass s.a.-Company Report
January 2010 £495
Diatos SA-Company Report
January 2010 £495
Disphar International BV-Company Report
January 2010 £495
Doetsch Grether AG-Company Report
January 2010 £495
Dong Sung Pharmaceutical Company Ltd.-Company Report
January 2010 £495
Dompe S.p.A.-Company Report
January 2010 £495
Diabetology Ltd-Company Report
January 2010 £495
DiaMedica Inc.-Company Report
January 2010 £495
Dermtek Pharmaceuticals Ltd-Company Report
January 2010 £495
DermaTech Pty Ltd-Company Report
January 2010 £495
Derma UK Ltd-Company Report
January 2010 £495
Desitin Arzneimittel GmbH-Company Report
January 2010 £495
DeveloGen AG-Company Report
January 2010 £495
DiaKine Therapeutics, Inc.-Company Report
January 2010 £495
Dexcel Pharma Technologies Ltd.-Company Report
January 2010 £495
Endotis Pharma-Company Report
January 2010 £495
Enkam Pharmaceuticals A/S-Company Report
January 2010 £495
Fovea Pharmaceuticals SA-Company Report
January 2010 £495
Formac Pharmaceuticals N.V.-Company Report
January 2010 £495
ForTe BV-Company Report
January 2010 £495
Franco-Indian Pharmaceuticals Pvt. Ltd.-Company Report
January 2010 £495
Fresenius Kabi AG-Company Report
January 2010 £495
Fusion Antibodies Ltd-Company Report
January 2010 £495
Fulford (India) Limited-Company Report
January 2010 £495
Fujimoto Pharmaceutical Corporation-Company Report
January 2010 £495
Flynn Pharma Ltd-Company Report
January 2010 £495
Flen Pharma-Company Report
January 2010 £495
Fidia farmaceutici S.p.A.-Company Report
January 2010 £495
FibroGen, Inc.-Company Report
January 2010 £495
Fertin Pharma A/S-Company Report
January 2010 £495
Finderm Farmaceutici s.r.l.-Company Report
January 2010 £495
FivePrime Therapeutics, Inc.-Company Report
January 2010 £495
Fleming Pharmaceuticals-Company Report
January 2010 £495
Flamingo Pharmaceuticals Ltd.-Company Report
January 2010 £495
Futura Medical plc-Company Report
January 2010 £495
G & W Laboratories, Inc.-Company Report
January 2010 £495
Geistlich-Company Report
January 2010 £495
Gary Pharmaceuticals P Limited-Company Report
January 2010 £495
Galenica s.a.-Company Report
January 2010 £495
Gemin X Pharmaceuticals, Inc.-Company Report
January 2010 £495
GenBioPro, Inc.-Company Report
January 2010 £495
Gene Signal International SA-Company Report
January 2010 £495
GenPhar, Inc.-Company Report
January 2010 £495
Galenica Ltd.-Company Report
January 2010 £495
Galen Limited-Company Report
January 2010 £495
GL PharmTech Corporation-Company Report
January 2010 £495
GEYMONAT S.p.A.-Company Report
January 2010 £495
GENESIS Pharma SA-Company Report
January 2010 £495
Gaco Pharmaceuticals.-Company Report
January 2010 £495
Gador S.A.-Company Report
January 2010 £495
Galderma SA-Company Report
January 2010 £495
Galapagos nv-Company Report
January 2010 £495
Ferozsons Laboratories Limited-Company Report
January 2010 £495
Ferndale Laboratories, Inc.-Company Report
January 2010 £495
Essex Bio-Technology Limited-Company Report
January 2010 £495
Essentialis, Inc.-Company Report
January 2010 £495
Eskayef Bangladesh Limited-Company Report
January 2010 £495
Esteve-Company Report
January 2010 £495
Ethypharm SA-Company Report
January 2010 £495
Eurodrug Laboratories-Company Report
January 2010 £495
Euphoric Pharmaceuticals (P) Ltd-Company Report
January 2010 £495
Errant Gene Therapeutics, LLC-Company Report
January 2010 £495
Eriochem S.A.-Company Report
January 2010 £495
Epiphany Biosciences, Inc.-Company Report
January 2010 £495
EpiGenesis Pharmaceuticals Inc-Company Report
January 2010 £495
Epeius Biotechnologies Corporation-Company Report
January 2010 £495
Epla Laboratories (Pvt.) Ltd.-Company Report
January 2010 £495
EquiTech Corporation-Company Report
January 2010 £495
Erimos Pharmaceuticals-Company Report
January 2010 £495
Equis Pharm Co., Ltd.-Company Report
January 2010 £495
Eurofarma-Company Report
January 2010 £495
Everett Laboratories, Inc.-Company Report
January 2010 £495
Falcon Pharmaceuticals, Ltd.-Company Report
January 2010 £495
Fabre-Kramer Pharmaceuticals, Inc.-Company Report
January 2010 £495
FSP GALENA-Company Report
January 2010 £495
Farmacija d.o.o.-Company Report
January 2010 £495
Farmaprojects S.A.-Company Report
January 2010 £495
Faron Pharmaceuticals Ltd.-Company Report
January 2010 £495
Farmoquimica S/A-Company Report
January 2010 £495
FIT Biotech Oyj Plc.-Company Report
January 2010 £495
FDC Ltd.-Company Report
January 2010 £495
Extrawell Pharmaceutical Holdings Limited-Company Report
January 2010 £495
ExonHit Therapeutics SA-Company Report
January 2010 £495
Evolva SA-Company Report
January 2010 £495
EyeGene, Inc.-Company Report
January 2010 £495
FAES FARMA-Company Report
January 2010 £495
FASgen, Inc.-Company Report
January 2010 £495
FARAN LABORATORIES sa-Company Report
January 2010 £495
DEY L.P.-Company Report
January 2010 £495
MOVETIS NV-Company Report
January 2010 £495
S.L.A. Pharma AG-Company Report
January 2010 £495
S.A Mithra Pharmaceuticals N.V-Company Report
January 2010 £495
S*BIO Pte Ltd-Company Report
January 2010 £495
SAWAI PHARMACEUTICAL CO.,LTD.-Company Report
January 2010 £495
SBI Biotech Co., Ltd.-Company Report
January 2010 £495
SGPharma Pvt. Ltd.-Company Report
January 2010 £495
SERB Laboratories-Company Report
January 2010 £495
SEDICO Pharmaceuticals Company-Company Report
January 2010 £495
Rusan Pharma Ltd.-Company Report
January 2010 £495
Rottapharm SpA-Company Report
January 2010 £495
Rohto Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Riyadh Pharma Medical & Cosmetic Products Co. Ltd-Company Report
January 2010 £495
Rimonyx Pharmaceuticals Ltd.-Company Report
January 2010 £495
Romark Laboratories, L.C.-Company Report
January 2010 £495
Rose Pharma A/S (formerly Gastrotech Pharma A/S)-Company Report
January 2010 £495
Rosemont Pharmaceuticals Ltd-Company Report
January 2010 £495
Rosedale Therapeutics-Company Report
January 2010 £495
SIFI S.p.A.-Company Report
January 2010 £495
SK Bio-Pharmaceuticals-Company Report
January 2010 £495
Samyang Corporation-Company Report
January 2010 £495
Sam Chun Dang Pharm. Co.,Ltd-Company Report
January 2010 £495
Sager Pharma-Company Report
January 2010 £495
SanBio, Inc.-Company Report
January 2010 £495
Sanbe Farma-Company Report
January 2010 £495
Sanochemia Pharmazeutika AG-Company Report
January 2010 £495
Sandoz International GmbH-Company Report
January 2010 £495
Sagent Pharmaceuticals, Inc.-Company Report
January 2010 £495
Saga Laboratories-Company Report
January 2010 £495
SOPHIA LABORATORIES-Company Report
January 2010 £495
SKYMAX LABORATORIES PVT. LTD.-Company Report
January 2010 £495
SK Chemicals Life Science (formerly Dong Shin Pharmaceutical Co., Ltd.)-Company Report
January 2010 £495
SR Medicare Pvt. Ltd.-Company Report
January 2010 £495
SRS Pharmaceuticals Pvt. Ltd.-Company Report
January 2010 £495
SWEDISH ORPHAN A/S-Company Report
January 2010 £495
SSP CO., LTD.-Company Report
January 2010 £495
Rib-X Pharmaceuticals, Inc.-Company Report
January 2010 £495
Reviva Pharmaceuticals, Inc.-Company Report
January 2010 £495
REPLICor Inc.-Company Report
January 2010 £495
RECORDATI SpA-Company Report
January 2010 £495
Zymenex A/S-Company Report
January 2010 £495
REVOTAR Biopharmaceuticals AG-Company Report
January 2010 £495
RFS Pharma, LLC-Company Report
January 2010 £495
RPG Life Sciences Ltd.-Company Report
January 2010 £495
ROWA Pharmaceuticals Ltd.-Company Report
January 2010 £495
RNL Bio Co., Ltd-Company Report
January 2010 £495
Zydus Cadila Healthcare Limited-Company Report
January 2010 £495
Zyber Pharmaceuticals, Inc.-Company Report
January 2010 £495
Zenotech Laboratories Ltd.-Company Report
January 2010 £495
Zelos Therapeutics Inc.-Company Report
January 2010 £495
Zealand Pharma A/S-Company Report
January 2010 £495
Zentiva, a.s. (formerly Leciva a.s.)-Company Report
January 2010 £495
Zenyaku Kogyo Co. Ltd.-Company Report
January 2010 £495
Zhejiang Huahai Pharmaceutical Co.,Ltd-Company Report
January 2010 £495
Zeria Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
RaQualia Pharma Inc.-Company Report
January 2010 £495
Rafa Laboratories, Ltd.-Company Report
January 2010 £495
Renovo Ltd.-Company Report
January 2010 £495
Reliance Life Sciences Pvt. Ltd.-Company Report
January 2010 £495
Rekah Pharmaceutical Industry Ltd.-Company Report
January 2010 £495
Representaciones e Investigaciones Medicas, S.A. de C.V-Company Report
January 2010 £495
Resolvyx Pharmaceuticals, Inc.-Company Report
January 2010 £495
Revance Therapeutics, Inc.-Company Report
January 2010 £495
Resverlogix Corp.-Company Report
January 2010 £495
Regulus Therapeutics-Company Report
January 2010 £495
Regulon, Inc-Company Report
January 2010 £495
Razi Vaccine & Serum Research Institute-Company Report
January 2010 £495
Rare Disease Therapeutics, Inc.-Company Report
January 2010 £495
Ranbaxy Laboratories Ltd.-Company Report
January 2010 £495
ReNeuron Group plc-Company Report
January 2010 £495
Reata Pharmaceuticals, Inc.-Company Report
January 2010 £495
Redox Pharmaceutical Corporation-Company Report
January 2010 £495
Reckitt Benckiser Group plc.-Company Report
January 2010 £495
Sanovel-Company Report
January 2010 £495
Santaris Pharma A/S-Company Report
January 2010 £495
Sopharma JSCo.-Company Report
January 2010 £495
Solvay S.A.-Company Report
January 2010 £495
Snowdon Pharmaceuticals Inc-Company Report
January 2010 £495
Sosei Group Corporation-Company Report
January 2010 £495
Sparsh Bio-Tech Pvt. Ltd.-Company Report
January 2010 £495
Spherics, Inc-Company Report
January 2010 £495
Specifar Pharmaceuticals-Company Report
January 2010 £495
Speciality European Pharma Limited-Company Report
January 2010 £495
SkinMedica, Inc.-Company Report
January 2010 £495
Sirtris Pharmaceuticals-Company Report
January 2010 £495
Silence Therapeutics plc (formerly SR Pharma plc)-Company Report
January 2010 £495
Sihuan Pharmaceutical Holdings Group Ltd.-Company Report
January 2010 £495
Sigma-Tau S.p.A.-Company Report
January 2010 £495
Sinclair Pharma plc-Company Report
January 2010 £495
Sino Biopharmaceutical Ltd.-Company Report
January 2010 £495
Sirnaomics, Inc.-Company Report
January 2010 £495
Sirion Therapeutics, Inc.-Company Report
January 2010 £495
Spirig Pharma Ltd.-Company Report
January 2010 £495
Spirogen Ltd.-Company Report
January 2010 £495
Summers Labs, Inc.-Company Report
January 2010 £495
Stragen Pharma SA-Company Report
January 2010 £495
Sterling Lab-Company Report
January 2010 £495
Summit plc-Company Report
January 2010 £495
Sun Pharmaceutical Industries Ltd.-Company Report
January 2010 £495
Sunward Pharmaceutical Pte Ltd-Company Report
January 2010 £495
Sunrise Pharmaceutical, Inc.-Company Report
January 2010 £495
SteriMax Inc.-Company Report
January 2010 £495
Stemline Therapeutics, Inc.-Company Report
January 2010 £495
Stallergenes-Company Report
January 2010 £495
St. Charles Pharmaceuticals-Company Report
January 2010 £495
Square Pharmaceuticals Ltd.-Company Report
January 2010 £495
Stallion Laboratories Pvt. Ltd.-Company Report
January 2010 £495
Standard Chem. & Pharm. Co., Ltd.-Company Report
January 2010 £495
Stelic Institute & Co.-Company Report
January 2010 £495
Star Laboratories (Pvt) Ltd.-Company Report
January 2010 £495
Sigma Pharmaceuticals Limited-Company Report
January 2010 £495
Shrooq PHARMA (PVT.) LTD.-Company Report
January 2010 £495
Scios Inc.-Company Report
January 2010 £495
Scil Technology GmbH-Company Report
January 2010 £495
Sciele Pharma, Inc.-Company Report
January 2010 £495
Searle Pakistan LTD.-Company Report
January 2010 £495
Sedona Laboratories, Inc.-Company Report
January 2010 £495
Semafore Pharmaceuticals, Inc. (formerly ComChem Technologies)-Company Report
January 2010 £495
Seikagaku Corporation-Company Report
January 2010 £495
SciGen Limited-Company Report
January 2010 £495
Scandinavian Clinical Nutrition AB-Company Report
January 2010 £495
Sanwa Kagaku Kenkyusho Co., Ltd.-Company Report
January 2010 £495
Santhera Pharmaceuticals AG-Company Report
January 2010 £495
Santen Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Sareum Ltd-Company Report
January 2010 £495
Sato Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Scancell Limited-Company Report
January 2010 £495
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)-Company Report
January 2010 £495
Senexis Limited-Company Report
January 2010 £495
Senju Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Shanghai Sunve Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Shanghai Harvest Pharmaceutical Co.Ltd-Company Report
January 2010 £495
Shanghai Fosun Pharmaceutical Group Co., Ltd.-Company Report
January 2010 £495
Shantha Biotechnics-Company Report
January 2010 £495
Shenzhen Salubris Pharmaceuticals Co., Ltd-Company Report
January 2010 £495
Shionogi & Co., Ltd.-Company Report
January 2010 £495
Shineway Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Shanghai Dongbao Biopharmaceutical Co., Ltd.-Company Report
January 2010 £495
Shalaks Pharmaceuticals Pvt. Ltd.-Company Report
January 2010 £495
Serometrix LLC-Company Report
January 2010 £495
Serentis Ltd-Company Report
January 2010 £495
Sequella, Inc.-Company Report
January 2010 £495
Serum Institute Of India Ltd.-Company Report
January 2010 £495
Servier-Company Report
January 2010 £495
Shaklee Corporation-Company Report
January 2010 £495
Sevapharma a. s.-Company Report
January 2010 £495
Zambon Company S.p.A.-Company Report
January 2010 £495
Zahravi Pharmaceutical Company-Company Report
January 2010 £495
Troikaa Pharmaceuticals Ltd.-Company Report
January 2010 £495
Tripep AB-Company Report
January 2010 £495
Trillium Therapeutics Inc.-Company Report
January 2010 £495
Trophos SA-Company Report
January 2010 £495
Twilight Litaka Pharma Ltd.-Company Report
January 2010 £495
UDL Laboratories, Inc.-Company Report
January 2010 £495
UCB S.A.-Company Report
January 2010 £495
Tzamal Medical Group Ltd-Company Report
January 2010 £495
Triax Pharmaceuticals, LLC.-Company Report
January 2010 £495
Tri-Med Pty Ltd-Company Report
January 2010 £495
TransPharma Medical Ltd.-Company Report
January 2010 £495
TransMolecular, Inc.-Company Report
January 2010 £495
Tramedico Holding B.V.-Company Report
January 2010 £495
TransTech Pharma, Inc.-Company Report
January 2010 £495
Transgene Biotek Limited-Company Report
January 2010 £495
Tranzyme Pharma Inc.-Company Report
January 2010 £495
Transgene S.A.-Company Report
January 2010 £495
UMN Pharma Inc.-Company Report
January 2010 £495
URL Pharma, Inc. (formerly United Research Laboratories and Mutual Pharmaceutical Company)-Company Report
January 2010 £495
VHB Life Sciences Limited-Company Report
January 2010 £495
Urban Nutrition, LLC-Company Report
January 2010 £495
Upsher-Smith Laboratories, Inc.-Company Report
January 2010 £495
VINS Bioproducts Ltd.-Company Report
January 2010 £495
VLST Corp.-Company Report
January 2010 £495
Vaccinogen, Inc.-Company Report
January 2010 £495
Vaccinex, Inc.-Company Report
January 2010 £495
United Biomedical, Inc.-Company Report
January 2010 £495
Unison Laboratories Co., Ltd-Company Report
January 2010 £495
Unichem Laboratories Ltd.-Company Report
January 2010 £495
Unibioscreen SA-Company Report
January 2010 £495
USV Limited-Company Report
January 2010 £495
Unicure Remedies Pvt. Ltd.-Company Report
January 2010 £495
Unimarck Healthcare Limited. (UHL)-Company Report
January 2010 £495
Unipharma-Company Report
January 2010 £495
Unipharm Ltd.-Company Report
January 2010 £495
Toyama Chemical Co.,Ltd.-Company Report
January 2010 £495
Torrent Pharmaceuticals Limited-Company Report
January 2010 £495
Temmler Pharma GmbH & Co. KG-Company Report
January 2010 £495
TTY BioPharm-Company Report
January 2010 £495
TTK Healthcare Ltd-Company Report
January 2010 £495
Thallion Pharmaceuticals Inc.-Company Report
January 2010 £495
The United Laboratories International Holdings Limited-Company Report
January 2010 £495
Therabel Group-Company Report
January 2010 £495
TheraQuest Biosciences-Company Report
January 2010 £495
Themis Medicare Ltd.-Company Report
January 2010 £495
TSUMURA & CO.-Company Report
January 2010 £495
TRx Pharma-Company Report
January 2010 £495
TOPIGEN Pharmaceuticals Inc.-Company Report
January 2010 £495
TMRC Co., Ltd.-Company Report
January 2010 £495
TIDAL LABORATORIES PVT. LTD.,-Company Report
January 2010 £495
TOSC INTERNATIONAL PVT. LTD.-Company Report
January 2010 £495
TRACON Pharmaceuticals, Inc.-Company Report
January 2010 £495
TRION Pharma GmbH-Company Report
January 2010 £495
TRB Chemedica International S.A.-Company Report
January 2010 £495
Theracos, Inc.-Company Report
January 2010 £495
Theraptosis S.A-Company Report
January 2010 £495
Tolerotech Inc.-Company Report
January 2010 £495
Toa Eiyo Ltd.-Company Report
January 2010 £495
Tillotts Pharma AG-Company Report
January 2010 £495
Tolerx, Inc.-Company Report
January 2010 £495
Topotarget A/S-Company Report
January 2010 £495
Torii Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Toray Industries, Inc.-Company Report
January 2010 £495
Tillomed Laboratories Ltd.-Company Report
January 2010 £495
Tibotec BVBA-Company Report
January 2010 £495
Three Rivers Pharmaceuticals-Company Report
January 2010 £495
Theratechnologies, Inc.-Company Report
January 2010 £495
Therapure Biopharma Inc.-Company Report
January 2010 £495
ThromboGenics NV-Company Report
January 2010 £495
Thrombotargets Corporation-Company Report
January 2010 £495
Tiber Laboratories, LLC-Company Report
January 2010 £495
Tianjin Pharmaceuticals Group Co., Ltd.-Company Report
January 2010 £495
Vakzine Projekt Management GmbH (VPM)-Company Report
January 2010 £495
Valeo Pharma Inc.-Company Report
January 2010 £495
Will-Pharma-Company Report
January 2010 £495
WhanIn Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Wellstat Therapeutics Corporation-Company Report
January 2010 £495
Winsome Laboratories Pvt Ltd.-Company Report
January 2010 £495
X-GEN Pharmaceuticals, Inc.-Company Report
January 2010 £495
Xencor-Company Report
January 2010 £495
Xel Pharmaceuticals, Inc.-Company Report
January 2010 £495
Xanodyne Pharmaceuticals, Inc. (formerly Xanodyne Pharmacal)-Company Report
January 2010 £495
Wellstat Biologics Corporation-Company Report
January 2010 £495
Wellspring Pharmaceutical Corporation-Company Report
January 2010 £495
WOCKHARDT LIMITED-Company Report
January 2010 £495
WINGS PHARMACEUTICALS PVT. LTD-Company Report
January 2010 £495
WILEX AG-Company Report
January 2010 £495
Wakamoto Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Wallace Pharmaceuticals Ltd.-Company Report
January 2010 £495
Waymade Healthcare plc-Company Report
January 2010 £495
Wanbury Limited-Company Report
January 2010 £495
Xeno Pharmaceuticals Phils, Inc.-Company Report
January 2010 £495
Xenome Ltd-Company Report
January 2010 £495
Yamazaki Teikokudo Co., Ltd.-Company Report
January 2010 £495
Yakult Honsha Co., Ltd.-Company Report
January 2010 £495
YUNGJIN PHARM. CO.,LTD-Company Report
January 2010 £495
Yash Pharma Laboratories Ltd.-Company Report
January 2010 £495
Yuhan Corporation-Company Report
January 2010 £495
ZARS Pharma-Company Report
January 2010 £495
Yung Shin Pharmaceutical-Company Report
January 2010 £495
YORK PHARMA PLC-Company Report
January 2010 £495
YOOYOUNG Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Xention Limited (formerly Xention Discovery Ltd)-Company Report
January 2010 £495
Xenon Pharmaceuticals Inc.-Company Report
January 2010 £495
Xenon Pharma.-Company Report
January 2010 £495
Xepa-Soul Pattinson (Malaysia) Sdn Bhd-Company Report
January 2010 £495
Xigen S.A.-Company Report
January 2010 £495
YASOO Health Inc.-Company Report
January 2010 £495
Xytis, Inc.-Company Report
January 2010 £495
WEX Pharmaceuticals Inc.-Company Report
January 2010 £495
Vivier Pharma Inc.-Company Report
January 2010 £495
Venus Remedies Limited-Company Report
January 2010 £495
Vee Excel Drugs & Pharmaceuticals Private Limited-Company Report
January 2010 £495
Vectura Group plc.-Company Report
January 2010 £495
Veropharm-Company Report
January 2010 £495
VersaPharm Incorporated-Company Report
January 2010 £495
Vichem Chemie Ltd.-Company Report
January 2010 £495
Verva Pharmaceuticals Pty Ltd.-Company Report
January 2010 £495
Vectorite Biomedica, Inc.-Company Report
January 2010 £495
Vaxon Biotech-Company Report
January 2010 £495
VasGene Therapeutics, Inc.-Company Report
January 2010 £495
Vantia Ltd-Company Report
January 2010 £495
Vanguard Pharmaceutical Corp-Company Report
January 2010 £495
Vascular Biogenics Ltd.-Company Report
January 2010 £495
Vaxart, Inc.-Company Report
January 2010 £495
Vaxine Pty. Ltd.-Company Report
January 2010 £495
Vaxin, Inc.-Company Report
January 2010 £495
Victory Pharma, Inc.-Company Report
January 2010 £495
Victus Inc.-Company Report
January 2010 £495
Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals)-Company Report
January 2010 £495
Vitabiotics Ltd.-Company Report
January 2010 £495
VistaPharm, Inc.-Company Report
January 2010 £495
Vital Pharmaceutical Holdings Limited (formerly Vital BioTech Holdings Limited)-Company Report
January 2010 £495
Vitane Pharmaceuticals Inc.-Company Report
January 2010 £495
Viventia Biotech, Inc.-Company Report
January 2010 £495
VitreoRetinal Technologies Inc.-Company Report
January 2010 £495
Vista Pharmaceuticals-Company Report
January 2010 £495
Vision Pharma, LLC-Company Report
January 2010 £495
Viralytics Ltd (formerly Psiron Ltd)-Company Report
January 2010 £495
Vida Labs Limited-Company Report
January 2010 £495
Vicus Therapeutics-Company Report
January 2010 £495
Virionics Corporation-Company Report
January 2010 £495
ViroBay Inc-Company Report
January 2010 £495
Viron Therapeutics Inc-Company Report
January 2010 £495
ViroMed Co., Ltd-Company Report
January 2010 £495
Sunway Biotech Co.Ltd.-Company Report
January 2010 £495
Supernus Pharmaceuticals, Inc.-Company Report
January 2010 £495
Presidio Pharmaceuticals, Inc.-Company Report
January 2010 £495
PregLem SA-Company Report
January 2010 £495
Prasco Laboratories-Company Report
January 2010 £495
Primus Pharmaceuticals, Inc.-Company Report
January 2010 £495
ProMetic Life Sciences Inc.-Company Report
January 2010 £495
Probiotec Limited-Company Report
January 2010 £495
Probiomed, S.A. de C.V-Company Report
January 2010 £495
ProStrakan Group plc-Company Report
January 2010 £495
Popular Pharmaceuticals Ltd.-Company Report
January 2010 £495
Polyphor Ltd-Company Report
January 2010 £495
Plethora Solutions Limited-Company Report
January 2010 £495
Plethico Pharmaceuticals Ltd.-Company Report
January 2010 £495
Pisa Farmaceutica Mexicana-Company Report
January 2010 £495
Plexxikon Inc-Company Report
January 2010 £495
Polaris Group-Company Report
January 2010 £495
Polymun Scientific Immunbiologische Forschung GmbH-Company Report
January 2010 £495
Polpharma SA-Company Report
January 2010 £495
Procaps SA-Company Report
January 2010 £495
Prolexys Pharmaceuticals, Inc-Company Report
January 2010 £495
Purdue Pharma L.P-Company Report
January 2010 £495
Protox Therapeutics Inc.-Company Report
January 2010 £495
Protez Pharmaceuticals-Company Report
January 2010 £495
Purzer Pharmaceutical Co. Ltd.-Company Report
January 2010 £495
Q-Med AB-Company Report
January 2010 £495
Qilu Pharmaceutical CO., LTD.-Company Report
January 2010 £495
QRxPharma Pty Ltd-Company Report
January 2010 £495
ProteomTech, Inc.-Company Report
January 2010 £495
Protemix Corporation Limited-Company Report
January 2010 £495
Pronova BioPharma ASA-Company Report
January 2010 £495
Proneuron Biotechnologies, Inc.-Company Report
January 2010 £495
Prometheus Laboratories, Inc.-Company Report
January 2010 £495
Proper Nutrition, Inc.-Company Report
January 2010 £495
Proreo Pharma AG-Company Report
January 2010 £495
Protein Sciences Corporation-Company Report
January 2010 £495
ProtAffin Biotechnologie AG-Company Report
January 2010 £495
Piramal Healthcare Limited (formerly Nicholas Piramal India Limited)-Company Report
January 2010 £495
Pinnacle Pharma del Peru S.A.C.-Company Report
January 2010 £495
PharmEste s.r.l.-Company Report
January 2010 £495
Pharis Biotec GmbH-Company Report
January 2010 £495
Pharco Pharmaceuticals Inc.-Company Report
January 2010 £495
Pharma Stulln GmbH-Company Report
January 2010 £495
PharmaEngine, Inc.-Company Report
January 2010 £495
PharmaMar-Company Report
January 2010 £495
PharmaIN Corporation-Company Report
January 2010 £495
PharmaEssentia Corp.-Company Report
January 2010 £495
Phafag AG-Company Report
January 2010 £495
Pfizer Limited-Company Report
January 2010 £495
Pei Li Pharmaceutical Ind. Co., Ltd.-Company Report
January 2010 £495
Pedinol Pharmacal Inc.-Company Report
January 2010 £495
Patrys Limited-Company Report
January 2010 £495
PepTcell Limited-Company Report
January 2010 £495
PepTx, Inc.-Company Report
January 2010 £495
Pevion Biotech Ltd.-Company Report
January 2010 £495
Peptimmune, Inc-Company Report
January 2010 £495
Pharmaceutical Associates, Inc.-Company Report
January 2010 £495
Pharmagenesis Inc-Company Report
January 2010 £495
Philusa Corporation-Company Report
January 2010 £495
Philogen S.p.A-Company Report
January 2010 £495
PhiloGene Inc.-Company Report
January 2010 £495
PhotoCure ASA-Company Report
January 2010 £495
Photopharmica Ltd-Company Report
January 2010 £495
Pieris AG-Company Report
January 2010 £495
Phynova Group Plc-Company Report
January 2010 £495
Pherin Pharmaceuticals, Inc.-Company Report
January 2010 £495
Phase 2 Discovery, Inc.-Company Report
January 2010 £495
Pharmascience Inc.-Company Report
January 2010 £495
Pharmaniaga Berhad-Company Report
January 2010 £495
Pharmalink AB-Company Report
January 2010 £495
Pharmathen S.A.-Company Report
January 2010 £495
Pharmbio Korea Co., Ltd-Company Report
January 2010 £495
Pharmstandard-Company Report
January 2010 £495
Pharminox Ltd-Company Report
January 2010 £495
Quark Pharmaceuticals, Inc.-Company Report
January 2010 £495
QuatRx Pharmaceuticals-Company Report
January 2010 £495
Liqvor CJSC-Company Report
January 2010 £495
Lipoxen-Company Report
January 2010 £495
Lipomed AG-Company Report
January 2010 £495
Living Cell Technologies Ltd-Company Report
January 2010 £495
Locus Pharmaceuticals, Inc.-Company Report
January 2010 £495
Luitpold Pharmaceuticals, Inc.-Company Report
January 2010 £495
Lotus Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Logical Therapeutics, Inc.-Company Report
January 2010 £495
Lipocine Inc.-Company Report
January 2010 £495
Lipicard Technologies Limited-Company Report
January 2010 £495
LifeCycle Pharma A/S-Company Report
January 2010 £495
LiPlasome Pharma A/S-Company Report
January 2010 £495
Leuchemix-Company Report
January 2010 £495
LifeTec Group Limited-Company Report
January 2010 £495
Light Sciences Oncology, Inc.-Company Report
January 2010 £495
Lion Corporation-Company Report
January 2010 £495
LigoCyte Pharmaceuticals, Inc.-Company Report
January 2010 £495
Lumen Therapeutics-Company Report
January 2010 £495
Lupin Ltd-Company Report
January 2010 £495
MISSION PHARMACEUTICALS LTD.-Company Report
January 2010 £495
MIKA Pharma GmbH-Company Report
January 2010 £495
MEDLEY PHARMACEUTICALS LTD.-Company Report
January 2010 £495
MN Pharmaceuticals-Company Report
January 2010 £495
Chikujee Therapeutics-Company Report
January 2010 £495
MacroGenics Inc.-Company Report
January 2010 £495
Maas BiolAB-Company Report
January 2010 £495
MEABCO A/S-Company Report
January 2010 £495
MDC Pharmaceuticals Pvt Ltd.-Company Report
January 2010 £495
Lytix Biopharma AS-Company Report
January 2010 £495
Lyka Labs Limited-Company Report
January 2010 £495
Lux Biosciences, Inc.-Company Report
January 2010 £495
M et P Pharma AG (formerly Mattern Pharmaceuticals AG)-Company Report
January 2010 £495
M.J. Group-Company Report
January 2010 £495
MAT Biopharma-Company Report
January 2010 £495
MACLEODS PHARMACEUTICALS LIMITED-Company Report
January 2010 £495
Lentigen Corporation-Company Report
January 2010 £495
Leksir Ltd.-Company Report
January 2010 £495
LTT Bio-Pharma Co., Ltd-Company Report
January 2010 £495
LIVZON Pharmaceutical Group Inc.-Company Report
January 2010 £495
LIBBS Farmaceutica Ltd-Company Report
January 2010 £495
LaborMed Pharma-Company Report
January 2010 £495
Laboratoires Carilene-Company Report
January 2010 £495
Laboratoires SMB-Company Report
January 2010 £495
Laboratoires Pierre Fabre SA-Company Report
January 2010 £495
LG Life Sciences Ltd.-Company Report
January 2010 £495
LFB-Company Report
January 2010 £495
Raazee Therapeutics (Pvt) Ltd.-Company Report
January 2010 £495
Quinnova Pharmaceuticals, Inc.-Company Report
January 2010 £495
Quest PharmaTech Inc. (formerly Altachem Pharma Ltd.)-Company Report
January 2010 £495
Radius Health Inc. (formerly NuVios, Inc.)-Company Report
January 2010 £495
LACER, S.A.-Company Report
January 2010 £495
LEO Pharma A/S-Company Report
January 2010 £495
LAVIPHARM Group-Company Report
January 2010 £495
Laboratoires Thea-Company Report
January 2010 £495
Laboratoires URGO S.A-Company Report
January 2010 £495
Laboratorios Zafiro, S.A. de C.V-Company Report
January 2010 £495
Laboratorios Salvat, S.A-Company Report
January 2010 £495
Laboratorios Phoenix-Company Report
January 2010 £495
Labtec GmbH-Company Report
January 2010 £495
Lannacher Heilmittel Gmbh-Company Report
January 2010 £495
Lawley Pharmaceuticals-Company Report
January 2010 £495
Lark Laboratories-Company Report
January 2010 £495
Laboratorios Manuell, S.A-Company Report
January 2010 £495
Laboratorios Juventus, S.A.-Company Report
January 2010 £495
Laboratorio Teuto-Company Report
January 2010 £495
Laboratorio Elea SACIFYA-Company Report
January 2010 £495
Laboratori Guidotti SpA-Company Report
January 2010 £495
Laboratorios Almirall, S.A.-Company Report
January 2010 £495
Laboratorios CINFA-Company Report
January 2010 £495
Laboratorios Grin, S.A. de C.V.-Company Report
January 2010 £495
Laboratorios Gebro Pharma, S.A.-Company Report
January 2010 £495
Pascual Laboratories Inc.-Company Report
January 2010 £495
Paratek Pharmaceuticals, Inc-Company Report
January 2010 £495
NOVAGALI PHARMA S.A-Company Report
January 2010 £495
NOBEL ILAC Sanayii ve Ticaret A.S.-Company Report
January 2010 £495
N-Gene Research Laboratories, Inc.-Company Report
January 2010 £495
NOXXON Pharma AG-Company Report
January 2010 £495
NTC S.r.L.-Company Report
January 2010 £495
Nicogen Inc.-Company Report
January 2010 £495
Nichi-iko Pharmaceutical Co., Ltd (formerly Nihon Iyakuhin Kogyo Co., Ltd)-Company Report
January 2010 £495
NicOx S.A.-Company Report
January 2010 £495
t2cure GmbH-Company Report
January 2010 £495
Tekmira Pharmaceuticals Corporation-Company Report
January 2010 £495
Tecnimede Group-Company Report
January 2010 £495
Techpool Bio-Pharma Co., LTD.-Company Report
January 2010 £495
Technologie Biolactis, Inc.-Company Report
January 2010 £495
Tehran Chemie Pharmaceutical Co.-Company Report
January 2010 £495
Teijin Pharma Limited-Company Report
January 2010 £495
Teikoku Seiyaku Co., Ltd.-Company Report
January 2010 £495
Teikoku Pharma USA, Inc.-Company Report
January 2010 £495
Nippon Chemiphar Co., Ltd.-Company Report
January 2010 £495
Nippon Kayaku Co., Ltd.-Company Report
January 2010 £495
Novelix Pharmaceuticals Inc-Company Report
January 2010 £495
NovaMed Pharmaceuticals Inc.-Company Report
January 2010 £495
Noscira, S.A. (formerly Neuropharma, S.A.)-Company Report
January 2010 £495
Novell Pharmaceutical Laboratories-Company Report
January 2010 £495
Novexel-Company Report
January 2010 £495
Nucitec, S.A. de C.V.-Company Report
January 2010 £495
Novopharm Limited-Company Report
January 2010 £495
Norwood Immunology Limited-Company Report
January 2010 £495
North China Pharmaceutical Group Corp-Company Report
January 2010 £495
Nissan Chemical Industries, Ltd.-Company Report
January 2010 £495
Nippon Zoki Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Nippon Shinyaku Co., Ltd.-Company Report
January 2010 £495
Nisshin Seifun Group Inc.-Company Report
January 2010 £495
Nitec Pharma AG-Company Report
January 2010 £495
Norgine-Company Report
January 2010 £495
Nobelpharma Co., Ltd.-Company Report
January 2010 £495
Taxolog, Inc.-Company Report
January 2010 £495
Tau Therapeutics-Company Report
January 2010 £495
Synokem Pharmaceuticals Limited-Company Report
January 2010 £495
Synmosa Biopharma Corporation-Company Report
January 2010 £495
Synmedic Laboratories-Company Report
January 2010 £495
Synosia Therapeutics (formerly Synosis Therapeutics)-Company Report
January 2010 £495
Synpac-Kingdom Pharmaceuticals Co Ltd-Company Report
January 2010 £495
Syntopix Group plc-Company Report
January 2010 £495
Synthon BV-Company Report
January 2010 £495
Synteza Ltd-Company Report
January 2010 £495
Syndax Pharmaceuticals, Inc.-Company Report
January 2010 £495
Syncom Formulations (India) Ltd-Company Report
January 2010 £495
Suven Life Sciences Limited-Company Report
January 2010 £495
Surface Logix, Inc.-Company Report
January 2010 £495
Supratek Pharma Inc-Company Report
January 2010 £495
Swiss Pharma Nigeria Limited-Company Report
January 2010 £495
Symphogen A/S-Company Report
January 2010 £495
Synairgen plc-Company Report
January 2010 £495
SynZyme Technologies LLC-Company Report
January 2010 £495
Syntrix Biosystems, Inc.-Company Report
January 2010 £495
Systopic Laboratories Pvt. ltd.-Company Report
January 2010 £495
Tanmo Pharmaceuticals-Company Report
January 2010 £495
Tampei Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Taligen Therapeutics, Inc.-Company Report
January 2010 £495
Targa Therapeutics Corp.-Company Report
January 2010 £495
TargeGen, Inc.-Company Report
January 2010 £495
TargetDrug-Company Report
January 2010 £495
Targepeutics, Inc.-Company Report
January 2010 £495
Talecris Biotherapeutics-Company Report
January 2010 £495
Takeda Pharmaceutical Company Limited-Company Report
January 2010 £495
TaiGen Biotechnology Co., Ltd.-Company Report
January 2010 £495
Tablets (India) Limited-Company Report
January 2010 £495
T3A Industrial-Company Report
January 2010 £495
Taiho Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Taisho Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Taiwan Panbiotic Laboratories Co. Ltd.-Company Report
January 2010 £495
Taiwan Liposome Company-Company Report
January 2010 £495
Numerate, Inc.-Company Report
January 2010 £495
Nuvo Research Inc. (formerly Dimethaid Research Inc.)-Company Report
January 2010 £495
PALAU PHARMA-Company Report
January 2010 £495
PAION-Company Report
January 2010 £495
Ozone Pharmaceuticals Ltd.-Company Report
January 2010 £495
PARI Pharma (formerly PARI Aerosol Research Institute)-Company Report
January 2010 £495
PDC Biotech GmbH-Company Report
January 2010 £495
PR Pharmaceuticals, Inc.-Company Report
January 2010 £495
PLx Pharma Inc.-Company Report
January 2010 £495
PH&T S.p.A.-Company Report
January 2010 £495
Oxford BioMedica plc-Company Report
January 2010 £495
Oxagen Limited-Company Report
January 2010 £495
Osmotica Pharmaceutical Corp.-Company Report
January 2010 £495
Ortin Laboratories Limited-Company Report
January 2010 £495
Ortho-McNeil, Inc.-Company Report
January 2010 £495
Osprey Pharmaceuticals Limited-Company Report
January 2010 £495
Othera Pharmaceuticals, Inc.-Company Report
January 2010 £495
Otsuka Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Otis Clapp and Buffington-Company Report
January 2010 £495
PT Bernofarm-Company Report
January 2010 £495
PT Darya-Varia Laboratoria Tbk-Company Report
January 2010 £495
Panacea Biotec Ltd-Company Report
January 2010 £495
Pamlab, L.L.C. (formerly Pan American Laboratories, Inc.)-Company Report
January 2010 £495
Paloma Pharmaceuticals, Inc.-Company Report
January 2010 £495
Panacea Pharmaceuticals, Inc.-Company Report
January 2010 £495
Pangenetics BV-Company Report
January 2010 £495
Pantarhei Bioscience-Company Report
January 2010 £495
Panjon Pharma Ltd.-Company Report
January 2010 £495
Paladin Labs Inc.-Company Report
January 2010 £495
Paddock Laboratories, Inc.-Company Report
January 2010 £495
PT. Pyridam Farma Tbk-Company Report
January 2010 £495
PT Kimia Farma Tbk-Company Report
January 2010 £495
PT Kalbe Farma Tbk.-Company Report
January 2010 £495
Pacgen Biopharmaceuticals Corporation-Company Report
January 2010 £495
Pacific Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Pacira Pharmaceuticals, Inc.-Company Report
January 2010 £495
Pacific Pharmaceuticals Limited-Company Report
January 2010 £495
Orivas-Company Report
January 2010 £495
Orion Corporation-Company Report
January 2010 £495
Odan Laboratories Ltd-Company Report
January 2010 £495
OctoPlus N.V.-Company Report
January 2010 £495
Octapharma AG-Company Report
January 2010 £495
Oftalmoquimica Ltda.-Company Report
January 2010 £495
Okairos S.r.l.-Company Report
January 2010 £495
Omega Laboratories Limited-Company Report
January 2010 £495
Okopharm GmbH-Company Report
January 2010 £495
Ochoa Laboratories Ltd.-Company Report
January 2010 £495
Ocera Therapeutics, Inc.-Company Report
January 2010 £495
OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd-Company Report
January 2010 £495
OM PHARMA-Company Report
January 2010 £495
Nycomed-Company Report
January 2010 £495
ORION Laboratories Pty Ltd-Company Report
January 2010 £495
ORLING spol. s r.o.-Company Report
January 2010 £495
Oboi Laboratories-Company Report
January 2010 £495
Oakwood Laboratories, L.L.C.-Company Report
January 2010 £495
Omega Pharma NV-Company Report
January 2010 £495
OmegaGenesis-Company Report
January 2010 £495
Orange Drugs Limited-Company Report
January 2010 £495
Onyvax Limited-Company Report
January 2010 £495
Onset Therapeutics-Company Report
January 2010 £495
Ordain Health Care Pvt. Ltd-Company Report
January 2010 £495
Orexo AB-Company Report
January 2010 £495
Orient Europharma Co., Ltd.-Company Report
January 2010 £495
Organogenesis Inc.-Company Report
January 2010 £495
Ono Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Onepharm-Company Report
January 2010 £495
OncoMune, LLC-Company Report
January 2010 £495
Omrix Biopharmaceuticals Inc-Company Report
January 2010 £495
Omeros Corporation-Company Report
January 2010 £495
Oncolys Biopharma Inc.-Company Report
January 2010 £495
Onconova Therapeutics Inc.-Company Report
January 2010 £495
Oncosense-Company Report
January 2010 £495
Oncoscience AG-Company Report
January 2010 £495
Maiden Pharmaceuticals Ltd.-Company Report
January 2010 £495
China Shineway Pharmaceutical Group Limited-Company Report
January 2010 £495
IL Dong Pharmaceutical Company-Company Report
January 2010 £495
IBSS BIOMED S.A.-Company Report
January 2010 £495
Hypermarcas S.A.-Company Report
January 2010 £495
ILS Inc. (formerly Ito Life Sciences Inc.)-Company Report
January 2010 £495
Ichor Medical Systems, Inc.-Company Report
January 2010 £495
Ilsung pharmaceuticals Co., Ltd-Company Report
January 2010 £495
Ikaria Holdings, Inc.-Company Report
January 2010 £495
Ikano Therapeutics, Inc. (ITI) (formerly Intranasal Therapeutics, Inc.)-Company Report
January 2010 £495
Hygeia Therapeutics, Inc.-Company Report
January 2010 £495
Huons Co., Ltd.-Company Report
January 2010 £495
Hindustan Antibiotics Limited-Company Report
January 2010 £495
Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG-Company Report
January 2010 £495
Henderson Morley plc-Company Report
January 2010 £495
Hindustan Biosynth Ltd-Company Report
January 2010 £495
Hualan Biological Engineering Inc.-Company Report
January 2010 £495
Human BioSciences, Inc.-Company Report
January 2010 £495
Huangshan Tianmu Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
ImmunoVaccine Technologies Inc.-Company Report
January 2010 £495
Implicit Bioscience Limited-Company Report
January 2010 £495
Institute of Medicinal Molecular Design, Inc. (IMMD)-Company Report
January 2010 £495
Institut Rosell-Lallemand-Company Report
January 2010 £495
Insight Pharmaceuticals Corp.-Company Report
January 2010 £495
Insys Therapeutics, Inc.-Company Report
January 2010 £495
ISA Pharmaceuticals B.V.-Company Report
January 2010 £495
Intellikine, Inc.-Company Report
January 2010 £495
IntelliPharmaCeutics Corp.-Company Report
January 2010 £495
Innovative Technologies-Company Report
January 2010 £495
Innate Therapeutics Limited (formerly Virionyx Corporation Limited)-Company Report
January 2010 £495
InNexus Biotechnology Inc.-Company Report
January 2010 £495
InCode BioPharmaceutics, Inc.-Company Report
January 2010 £495
ImuThes Therapeutics Ltd.-Company Report
January 2010 £495
Incepta Pharmaceuticals Ltd.-Company Report
January 2010 £495
Indian Immunologicals Limited-Company Report
January 2010 £495
Innate Pharma-Company Report
January 2010 £495
Indus Biotech Private Limited-Company Report
January 2010 £495
Helicon Therapeutics, Inc.-Company Report
January 2010 £495
Hebi Health Care-Company Report
January 2010 £495
GlaxoSmithKline plc-Company Report
January 2010 £495
GlaxoSmithKline K.K.-Company Report
January 2010 £495
Getwell Life Sciences India Pvt. Ltd.-Company Report
January 2010 £495
Gliknik Inc.-Company Report
January 2010 £495
Global Napi Pharmaceuticals-Company Report
January 2010 £495
GlycoMar Limited-Company Report
January 2010 £495
Globalpharma Co LLC-Company Report
January 2010 £495
Global Pharma Healthcare Pvt Ltd-Company Report
January 2010 £495
GW Pharmaceuticals plc-Company Report
January 2010 £495
Gentium S.p.A.-Company Report
January 2010 £495
Genepharm Group-Company Report
January 2010 £495
Genentech, Inc.-Company Report
January 2010 £495
GenPharma International Pvt.Ltd.-Company Report
January 2010 £495
Genericon Pharma-Company Report
January 2010 £495
Genexo sp. z o.o.-Company Report
January 2010 £495
Genopharm-Company Report
January 2010 £495
Genomma Lab Internacional, S.A.B de C.V.-Company Report
January 2010 £495
Great Eastern Drug Co. Ltd.-Company Report
January 2010 £495
GreenPeptide Co., Ltd.-Company Report
January 2010 £495
Harson Laboratories-Company Report
January 2010 £495
HELP S.A.-Company Report
January 2010 £495
Han Wha Pharma Co., Ltd.-Company Report
January 2010 £495
Hasco-Lek-Company Report
January 2010 £495
Health Protection Agency-Company Report
January 2010 £495
Heat Biologics, Inc-Company Report
January 2010 £495
Healthcare Brands International Limited-Company Report
January 2010 £495
Hainan Haiyao Co., Ltd.-Company Report
January 2010 £495
Hainan Hailing Pharmaceutical Corp. Ltd.-Company Report
January 2010 £495
Grupo TechSphere-Company Report
January 2010 £495
Grupo Azevedos-Company Report
January 2010 £495
Group Pharmaceuticals Ltd.-Company Report
January 2010 £495
Guangzhou Baiyunshan Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Guilin Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
H. Lundbeck A/S-Company Report
January 2010 £495
Gulf Pharmaceutical Industries (JULPHAR)-Company Report
January 2010 £495
Intradigm Corporation-Company Report
January 2010 £495
Inventia Healthcare Private Limited (formerly Themis Laboratories Private Ltd)-Company Report
January 2010 £495
Laboratorios Silanes, S.A. de C.V.-Company Report
January 2010 £495
Laboratorios Serral-Company Report
January 2010 £495
Laboratorios SAVAL-Company Report
January 2010 £495
Laboratorios Solfran S.A.-Company Report
January 2010 £495
Landsteiner Scientific, S.A. de C.V.-Company Report
January 2010 £495
LegoChem Biosciences, Inc (LCB)-Company Report
January 2010 £495
Lee's Pharmaceutical Holdings Ltd-Company Report
January 2010 £495
Lantibio, Inc.-Company Report
January 2010 £495
Laboratorios Normon S.A.-Company Report
January 2010 £495
Laboratorios Hormona-Company Report
January 2010 £495
Laboratoires Mayoly Spindler-Company Report
January 2010 £495
Laboratoires Genevrier-Company Report
January 2010 £495
Laboratoires Expanscience S.A.-Company Report
January 2010 £495
Laboratorios Rubio, S.A.-Company Report
January 2010 £495
LAILA Pharmaceuticals Pvt. Ltd.-Company Report
January 2010 £495
Laboratorios Casen Fleet-Company Report
January 2010 £495
LEOVAN PHARMACEUTICALS-Company Report
January 2010 £495
Life Line Biotech Ltd.-Company Report
January 2010 £495
Lifecare Innovations Pvt. Ltd.-Company Report
January 2010 £495
MacuSight, Inc.-Company Report
January 2010 £495
MEDGEN Laboratories, Inc.-Company Report
January 2010 £495
Luye Pharma Group Ltd. (formerly AsiaPharm Group Ltd.)-Company Report
January 2010 £495
Magis Farmaceutici S.p.A.-Company Report
January 2010 £495
Mankind Pharma Limited-Company Report
January 2010 £495
Maroon Biotech Corp.-Company Report
January 2010 £495
Marksans Pharma-Company Report
January 2010 £495
Lundbeck Inc. (formerly OVATION Pharmaceuticals, Inc.)-Company Report
January 2010 £495
Louis Widmer AG-Company Report
January 2010 £495
Lincoln Pharmaceuticals Ltd-Company Report
January 2010 £495
Limerick BioPharma, Inc. (formerly Limerick NeuroSciences, Inc.)-Company Report
January 2010 £495
Lightlake Sinclair Ltd.-Company Report
January 2010 £495
Liomont-Company Report
January 2010 £495
Llorens Pharmaceutical International Division, Inc.-Company Report
January 2010 £495
Lorus Therapeutics Inc-Company Report
January 2010 £495
LPC Pharmaceuticals Ltd-Company Report
January 2010 £495
Labopharm Inc-Company Report
January 2010 £495
LABORATORIOS FARMACEUTICOS ROVI, S.A-Company Report
January 2010 £495
JOSWE Medical-Company Report
January 2010 £495
Jenrin Discovery, Inc.-Company Report
January 2010 £495
Jenapharm GmbH & Co. KG-Company Report
January 2010 £495
Jiangsu Hansen Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Jiangsu Lianhuan Pharmaceutical Group-Company Report
January 2010 £495
Joriver Research & development Center-Company Report
January 2010 £495
Jordanian Pharmaceutical Manufacturing Co. PLC-Company Report
January 2010 £495
Jintan SongSheng medical and chemical Co., Ltd-Company Report
January 2010 £495
Jazeera Pharmaceutical Industries-Company Report
January 2010 £495
Janssen Pharmaceutical K.K.-Company Report
January 2010 £495
Isotechnika Pharma Inc.-Company Report
January 2010 £495
Iroko Pharmaceuticals, LLC-Company Report
January 2010 £495
Ipsen-Company Report
January 2010 £495
JAKA 80 AD-Company Report
January 2010 £495
JHP Pharmaceuticals, LLC-Company Report
January 2010 £495
Jamjoom Pharma-Company Report
January 2010 £495
Jade Pharmaceutical Inc-Company Report
January 2010 £495
Jubilant Organosys Ltd.-Company Report
January 2010 £495
Juvaris BioTherapeutics, Inc-Company Report
January 2010 £495
Kotra Pharma (M) Sdn. Bhd. (KPM)-Company Report
January 2010 £495
Kotobuki Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Korean Drug Co., Ltd.-Company Report
January 2010 £495
Kurtsan Pharmaceuticals Inc.-Company Report
January 2010 £495
Kuwait Saudi Pharmaceutical Industries Co.-Company Report
January 2010 £495
LABORATOIRES LISAPHARM-Company Report
January 2010 £495
Kyto BioPharma Inc-Company Report
January 2010 £495
Korea United Pharm, Inc.-Company Report
January 2010 £495
KV Pharmaceutical Company-Company Report
January 2010 £495
Karus Therapeutics-Company Report
January 2010 £495
Kaigen Co., Ltd.-Company Report
January 2010 £495
KAEL-GemVax-Company Report
January 2010 £495
Kelun Pharmaceutical-Company Report
January 2010 £495
Kendrick Farmaceutica-Company Report
January 2010 £495
Khandelwal Laboratories Pvt. Ltd-Company Report
January 2010 £495
Keryos SpA-Company Report
January 2010 £495
GenMont Biotech Inc.-Company Report
January 2010 £495
GenKyoTex S.A.-Company Report
January 2010 £495
Centocor Ortho Biotech Inc.-Company Report
January 2010 £495
CIS Pharma-Company Report
January 2010 £495
CHUGAI PHARMACEUTICAL CO., LTD-Company Report
January 2010 £495
CepTor Corporation-Company Report
January 2010 £495
CerRx, Inc.-Company Report
January 2010 £495
Charleston Laboratories, Inc.-Company Report
January 2010 £495
Changzhou Pharmaceutical Factory-Company Report
January 2010 £495
Changzhou Fangyuan Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Celtic Pharma Management L.P-Company Report
January 2010 £495
Celtic Biotech Ltd.-Company Report
January 2010 £495
CellAct Pharma GmbH-Company Report
January 2010 £495
Cell Biotech Co., Ltd-Company Report
January 2010 £495
Celentyx Limited-Company Report
January 2010 £495
Cellerix-Company Report
January 2010 £495
Celleron Therapeutics Ltd-Company Report
January 2010 £495
Celon Laboratories Limited-Company Report
January 2010 £495
Cellmid Ltd-Company Report
January 2010 £495
ChemGenex Pharmaceuticals Limited-Company Report
January 2010 £495
China Medical System Holdings Limited-Company Report
January 2010 £495
Croma Pharma GmbH-Company Report
January 2010 £495
Covalon Technologies Ltd.-Company Report
January 2010 £495
Cougar Biotechnology, Inc.-Company Report
January 2010 £495
Crown Laboratories, Inc.-Company Report
January 2010 £495
Crucell N.V.-Company Report
January 2010 £495
Cytos Biotechnology AG-Company Report
January 2010 £495
Cytorex Biosciences, Inc-Company Report
January 2010 £495
Cosar Pharmaceutical Co.-Company Report
January 2010 £495
CorePharma LLC-Company Report
January 2010 £495
Clinuvel Pharmaceuticals Limited-Company Report
January 2010 £495
Chunggei Pharm. Co., Ltd-Company Report
January 2010 £495
Chinoin Pharmaceutical Products, S.A DE C.V-Company Report
January 2010 £495
Cognosci, Inc.-Company Report
January 2010 £495
Combe Incorporated-Company Report
January 2010 £495
Cooper Maroc-Company Report
January 2010 £495
Consilient Health Ltd.-Company Report
January 2010 £495
CeNeRx BioPharma, Inc.-Company Report
January 2010 £495
Catalyst Biosciences Inc.-Company Report
January 2010 £495
Biotecnol SA-Company Report
January 2010 £495
Biosyntech Inc-Company Report
January 2010 £495
Bionucleon S.r.l.-Company Report
January 2010 £495
Biotica Technology Limited-Company Report
January 2010 £495
Biovel Life Sciences (P) Limited-Company Report
January 2010 £495
Blackmores-Company Report
January 2010 £495
Biovista Inc.-Company Report
January 2010 £495
Bioven Sdn. Bhd.-Company Report
January 2010 £495
Bioniche Pharma USA, LLC-Company Report
January 2010 £495
Bioniche Life Sciences Inc-Company Report
January 2010 £495
Biocon Ltd-Company Report
January 2010 £495
Bioclonetics Inc-Company Report
January 2010 £495
Biochem Pharmaceutical Industries Ltd.-Company Report
January 2010 £495
Bioiberica, S.A.-Company Report
January 2010 £495
Biokine Therapeutics Ltd.-Company Report
January 2010 £495
Biomeks-Company Report
January 2010 £495
Biolotus Biotech-Company Report
January 2010 £495
Bluefish Pharmaceuticals AB-Company Report
January 2010 £495
Borshchahivskiy Chemical-Pharmaceutical Plant-Company Report
January 2010 £495
Calmune Corporation-Company Report
January 2010 £495
Calistoga Pharmaceuticals, Inc.-Company Report
January 2010 £495
Cadila Pharmaceuticals Limited-Company Report
January 2010 £495
Camus Pharma Pvt. Ltd.-Company Report
January 2010 £495
Canixa Life Sciences-Company Report
January 2010 £495
Cardiome Pharma Corp.-Company Report
January 2010 £495
Caplin Point Laboratories Ltd-Company Report
January 2010 £495
CCM Pharmaceuticals Sdn Bhd-Company Report
January 2010 £495
CCM Duopharma Biotech Bhd (CCMD)-Company Report
January 2010 £495
Brawn Pharmaceuticals Limited-Company Report
January 2010 £495
BrainCells Inc.-Company Report
January 2010 £495
Bracco Group-Company Report
January 2010 £495
Bristol-Myers K.K.-Company Report
January 2010 £495
Broad Intelligence International Pharmaceutical Holdings Limited.-Company Report
January 2010 £495
C.B. Fleet Company, Inc.-Company Report
January 2010 £495
Burzynski Research Institute, Inc-Company Report
January 2010 £495
DEMO S.A.-Company Report
January 2010 £495
DESMA PHARMA Group-Company Report
January 2010 £495
Functional Genetics Inc.-Company Report
January 2010 £495
FunZyme BioTechnologies S.A.-Company Report
January 2010 £495
Fuji Chemical Industry Co., Ltd.-Company Report
January 2010 £495
EMS Sigma Pharma Group-Company Report
January 2010 £495
EXIR PHARMACEUTICAL CO.-Company Report
January 2010 £495
Empree Medicaments (India) Pvt. Ltd.-Company Report
January 2010 £495
Elysium Pharmaceuticals Ltd.-Company Report
January 2010 £495
EluSys Therapeutics, Inc.-Company Report
January 2010 £495
Fresenius SE-Company Report
January 2010 £495
Fresenius Kabi Oncology Ltd. (formerly Dabur Pharma Limited)-Company Report
January 2010 £495
Fidson Healthcare Plc-Company Report
January 2010 £495
Ferring International Center S.A.-Company Report
January 2010 £495
Feron Life Sciences-Company Report
January 2010 £495
Foamix Ltd.-Company Report
January 2010 £495
Fornix Biosciences N.V.-Company Report
January 2010 £495
Freedom Eye Ltd-Company Report
January 2010 £495
Fourrts (India) Laboratories Pvt.Limited-Company Report
January 2010 £495
Empresas Andromaco S. A.-Company Report
January 2010 £495
Endacea, Inc.-Company Report
January 2010 £495
Gamida Cell Ltd.-Company Report
January 2010 £495
Galenika a.d.-Company Report
January 2010 £495
GANYMED Pharmaceuticals AG-Company Report
January 2010 £495
Ganeden Biotech, Inc.-Company Report
January 2010 £495
Garnet BioTherapeutics (formerly Neuronyx, Inc.)-Company Report
January 2010 £495
Gemini Pharmaceuticals Limited-Company Report
January 2010 £495
Gedeon Richter Plc.-Company Report
January 2010 £495
GA Pharmaceuticals SA-Company Report
January 2010 £495
EyeGate Pharmaceuticals, Inc-Company Report
January 2010 £495
Epoch Pharmaceuticals, Inc.-Company Report
January 2010 £495
EpiVax, Inc.-Company Report
January 2010 £495
Ensemble Discovery-Company Report
January 2010 £495
Esperion Therapeutics, Inc.-Company Report
January 2010 £495
Eurand N.V.-Company Report
January 2010 £495
Evotec AG-Company Report
January 2010 £495
Eusa Pharma (Europe) Ltd.-Company Report
January 2010 £495
Fem Care Pharma Ltd.-Company Report
January 2010 £495
Farmapol Spolka z o.o.-Company Report
January 2010 £495
Destiny Pharma, Ltd.-Company Report
January 2010 £495
Desano-Company Report
January 2010 £495
DermAvance Pharmaceuticals, Inc.-Company Report
January 2010 £495
Development Center for Biotechnology (DCB)-Company Report
January 2010 £495
Dey's Medical Stores (Manufacturing) Limited-Company Report
January 2010 £495
DM Pharma-Company Report
January 2010 £495
Diamyd Medical AB-Company Report
January 2010 £495
Demegen, Inc.-Company Report
January 2010 £495
Deef Pharmaceutical Company Saudi Arabia Go-Company Report
January 2010 £495
Daana Pharmaceutical Company-Company Report
January 2010 £495
DIREVO Industrial Biotechnology GmbH-Company Report
January 2010 £495
DIFFUCAP-Company Report
January 2010 £495
Dae han New Pharm Co., Ltd.-Company Report
January 2010 £495
Dar Al Dawa Development & Investment Co. Ltd.-Company Report
January 2010 £495
Davi II - Farmaceutica S.A.-Company Report
January 2010 £495
Daval International Ltd-Company Report
January 2010 £495
DoNatur GmbH-Company Report
January 2010 £495
Dr Reddys Laboratories Ltd-Company Report
January 2010 £495
Eli Lilly Japan K.K.-Company Report
January 2010 £495
Eisai Co., Ltd.-Company Report
January 2010 £495
Eiger BioPharmaceuticals, Inc.-Company Report
January 2010 £495
F. Hoffmann-La Roche Ltd-Company Report
January 2010 £495
FCB-Pharmicell Co.,Ltd.-Company Report
January 2010 £495
FPL Pharma-Company Report
January 2010 £495
FIBREX Medical Inc.-Company Report
January 2010 £495
Egyptian International Pharmaceutical Industries Co. (EIPICO)-Company Report
January 2010 £495
Eczacibasi-Zentiva-Company Report
January 2010 £495
Dr. Ritsert Pharma GmbH & Co KG-Company Report
January 2010 £495
Dr. R. Pfleger Chemische Fabrik GmbH-Company Report
January 2010 £495
Dr. F. Frik Ilac San. Ve Tic. A. S.-Company Report
January 2010 £495
Dream Pharma Corp.-Company Report
January 2010 £495
Eagle Pharmaceuticals Pty Ltd-Company Report
January 2010 £495
Ecopharm-Company Report
January 2010 £495
Ecobi Farmaceutici s.a.s.-Company Report
January 2010 £495
MaxCyte, Inc-Company Report
January 2010 £495
Medagro International-Company Report
January 2010 £495
Sorbent Therapeutics, Inc.-Company Report
January 2010 £495
SoluBest-Company Report
January 2010 £495
SkyePharma Plc-Company Report
January 2010 £495
Sothema-Company Report
January 2010 £495
South African Tuberculosis Vaccine Initiative (SATVI)-Company Report
January 2010 £495
STADA Arzneimittel AG-Company Report
January 2010 £495
Spinal Cord Therapeutics GmbH (SCT) (formerly Neuraxo Biopharmaceuticals GmbH)-Company Report
January 2010 £495
SpePharm Holding BV-Company Report
January 2010 £495
Sinsin Pharmaceutical Co. Ltd-Company Report
January 2010 £495
Sinobiopharma, Inc.-Company Report
January 2010 £495
Sigmapharm Arzneimittel GmbH & Co KG-Company Report
January 2010 £495
Siena Biotech S.p.A.-Company Report
January 2010 £495
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd-Company Report
January 2010 £495
Silarx Pharmaceuticals Inc-Company Report
January 2010 £495
Silom Medical Co Ltd-Company Report
January 2010 £495
SimcereÿPharmaceutical Group-Company Report
January 2010 £495
Silvestre Labs-Company Report
January 2010 £495
Star Drugs and Research Labs Ltd.-Company Report
January 2010 £495
Starpharma Holdings Ltd-Company Report
January 2010 £495
Systagenix Wound Management-Company Report
January 2010 £495
Synerx Pharma-Company Report
January 2010 £495
Synergy Healthcare Limited-Company Report
January 2010 £495
TCA Cellular Therapy, LLC-Company Report
January 2010 £495
THE ARAB PHARMACEUTICAL MANUFACTURING CO. LTD. (APM)-Company Report
January 2010 £495
Taiwan Biotech Co., Ltd.-Company Report
January 2010 £495
Taejoon Pharma Co., Ltd.-Company Report
January 2010 £495
Synageva BioPharma (formerly AviGenics, Inc.)-Company Report
January 2010 £495
Sylentis S.A.U.-Company Report
January 2010 £495
Streuli Pharma AG-Company Report
January 2010 £495
Stewart-Jackson Pharmacal, Inc.-Company Report
January 2010 £495
Stem Cell Therapeutics Corp.-Company Report
January 2010 £495
Strides Arcolab Limited-Company Report
January 2010 £495
Sunways India Pvt. Ltd.-Company Report
January 2010 £495
Sygnis Pharma AG-Company Report
January 2010 £495
Surya Pharmaceutical Limited-Company Report
January 2010 £495
Shreya Life Sciences Pvt. Ltd.-Company Report
January 2010 £495
SSL International plc-Company Report
January 2010 £495
Seoul Pharma Co., Ltd.-Company Report
January 2010 £495
Sentinel Oncology Limited-Company Report
January 2010 £495
Seaford Pharmaceuticals-Company Report
January 2010 £495
Sepracor Inc.-Company Report
January 2010 £495
Sepracor Pharmaceuticals, Inc. (formerly Oryx Pharmaceuticals Inc.)-Company Report
January 2010 £495
Shalina Healthcare-Company Report
January 2010 £495
Shaanxi Jiali Pharmaceuticals Co., Ltd.-Company Report
January 2010 £495
Servier Canada Inc-Company Report
January 2010 £495
SEPS Pharma NV-Company Report
January 2010 £495
sanofi-aventis K.K.-Company Report
January 2010 £495
Sangart, Inc.-Company Report
January 2010 £495
Samsung Pharm-Company Report
January 2010 £495
Samil Pharm. Co. Ltd.-Company Report
January 2010 £495
Sanjivani Paranteral, Ltd.-Company Report
January 2010 £495
Sanofi-aventis-Company Report
January 2010 £495
Santen Oy-Company Report
January 2010 £495
Sante Naturelle A.G. Ltd-Company Report
January 2010 £495
Shandong Lukang Pharmaceutical Co., Ltd-Company Report
January 2010 £495
Shandong Luoxin Pharmacy Stock Co., Ltd.-Company Report
January 2010 £495
Shenzhen Neptunus Interlong Bio-Tech Co., Ltd.-Company Report
January 2010 £495
Shenzhen Mellow Hope Pharm Industrial Co., Ltd.-Company Report
January 2010 £495
Shenzhen Main Luck Pharmaceuticals Inc.-Company Report
January 2010 £495
Shenzhen Zhijun Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Shifa Pharmaceutical Industries-Company Report
January 2010 £495
SRI International-Company Report
January 2010 £495
Shinpoong Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
ShenZhen Hybio Engineering Co., Ltd.-Company Report
January 2010 £495
Sharon Bio Medicine Limited (formerly Sharon Pharma Chem Limited)-Company Report
January 2010 £495
Shanghai Trifecta Pharma Ltd.-Company Report
January 2010 £495
Shanghai Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Shanghai CP Guojian Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Shanghai United Cell Biotechnology Co., Ltd.-Company Report
January 2010 £495
Shanghai Zhongxi Pharmaceutical co., Ltd.-Company Report
January 2010 £495
Shaphaco Pharmaceutical-Company Report
January 2010 £495
Shanxi Weiqida Pharmaceutical Co., Ltd-Company Report
January 2010 £495
Tallinna Farmaatsiatehase AS (TFT)-Company Report
January 2010 £495
Tasly Group-Company Report
January 2010 £495
Wuhan Grand Pharmaceutical Group Co., Ltd-Company Report
January 2010 £495
WraSer Pharmaceuticals-Company Report
January 2010 £495
WOORIDUL LIFE SCIENCES LTD-Company Report
January 2010 £495
Wuhan Humanwell Hi-Tech Industry Co., LTD.-Company Report
January 2010 £495
Wuyi International Pharmaceutical Company Limited-Company Report
January 2010 £495
Xi'an Libang Pharmaceuticals Co., Ltd-Company Report
January 2010 £495
Xi'an Hui Tian Blood Products Co., Ltd.-Company Report
January 2010 £495
XBiotech USA, Inc.-Company Report
January 2010 £495
WINTAC LIMITED-Company Report
January 2010 £495
Wellstat Vaccines, LLC-Company Report
January 2010 £495
Vitalis S.A. C.I.-Company Report
January 2010 £495
Vitabalans Oy-Company Report
January 2010 £495
Virostatics, srl-Company Report
January 2010 £495
Vivimed Labs Limited-Company Report
January 2010 £495
Vybion, Inc (formerly Viral Therapeutics, Inc.)-Company Report
January 2010 £495
Welichem Biotech Inc.-Company Report
January 2010 £495
Wampole Canada Inc.-Company Report
January 2010 £495
YM BioSciences Inc.-Company Report
January 2010 £495
Y's Therapeutics Co., Limited-Company Report
January 2010 £495
Zosano Pharma, Inc.-Company Report
January 2010 £495
Zhejiang Jingxin Pharmaceutical Co., Ltd-Company Report
January 2010 £495
Zhejiang Fengan Biopharmaceutical Co., Ltd-Company Report
January 2010 £495
Zytras Life Sciences-Company Report
January 2010 £495
Biogen Idec: Pipeline - Products - Performance - Potential
January 2010 £595
Dainippon Sumitomo: Pipeline, Products, Performance, Potential
January 2010 £595
UCB: Pipeline - Products - Performance - Potential
January 2010 £595
Y's Therapeutics Co., Limited-Company Report
January 2010 £495
Xi'an Libang Pharmaceuticals Co., Ltd-Company Report
January 2010 £495
YuSheng Pharmaceutical Co.-Company Report
January 2010 £495
Yes Biotech Laboratories Ltd.-Company Report
January 2010 £495
Yaupon Therapeutics, Inc.-Company Report
January 2010 £495
Yuyu Pharma, Inc.-Company Report
January 2010 £495
Zeon LifeSciences Limited-Company Report
January 2010 £495
Xi'an Hui Tian Blood Products Co., Ltd.-Company Report
January 2010 £495
Zhejiang Deyer Pharmaceutical Co., Ltd-Company Report
January 2010 £495
Versartis, Inc.-Company Report
January 2010 £495
Vernalis plc-Company Report
January 2010 £495
Torque Pharmaceuticals Pvt. Ltd.-Company Report
January 2010 £495
Tianjin Zhongxin Pharmaceutical Group Co., Ltd-Company Report
January 2010 £495
Thrasos, Inc.-Company Report
January 2010 £495
Towa Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Tragara Pharmaceuticals, Inc.-Company Report
January 2010 £495
Transave, Inc.-Company Report
January 2010 £495
TransDermal Technologies, Inc.-Company Report
January 2010 £495
Thornton and Ross Limited-Company Report
January 2010 £495
TRAPHACO Joint Stock Company-Company Report
January 2010 £495
Tego Science, Inc.-Company Report
January 2010 £495
TechnoVax, Inc.-Company Report
January 2010 £495
TcL Pharma SAS-Company Report
January 2010 £495
Terumo Corp-Company Report
January 2010 £495
Teva-Tuteur-Company Report
January 2010 £495
Therametics, LLC.-Company Report
January 2010 £495
The Government Pharmaceutical Organization-Company Report
January 2010 £495
Transition Therapeutics Inc.-Company Report
January 2010 £495
Translational Research, Ltd.-Company Report
January 2010 £495
Validus Pharmaceuticals, Inc.-Company Report
January 2010 £495
Valentis-Company Report
January 2010 £495
Vaishnavi Lifescience Pvt. Ltd.-Company Report
January 2010 £495
VaxInnate Corporation-Company Report
January 2010 £495
VectorLogics, Inc.-Company Report
January 2010 £495
Venkat Pharma Limited-Company Report
January 2010 £495
Vemedia B.V.-Company Report
January 2010 £495
United Pharmaceuticals-Company Report
January 2010 £495
United Laboratories Inc.-Company Report
January 2010 £495
Trius Therapeutics (formerly Rx3 Pharmaceuticals, Inc.)-Company Report
January 2010 £495
Trigen Pharma International-Company Report
January 2010 £495
Transport Pharmaceuticals, Inc.-Company Report
January 2010 £495
UAS Laboratories-Company Report
January 2010 £495
UCB Japan Co., Ltd.-Company Report
January 2010 £495
Uni-Bio Science Group Ltd.-Company Report
January 2010 £495
UNI PHARMA-Company Report
January 2010 £495
Sagmel, Inc.-Company Report
January 2010 £495
SANAVITA ENTERPRISES, INC.-Company Report
January 2010 £495
Nihon Nohyaku Co Ltd-Company Report
January 2010 £495
Nigerian-German Chemicals Plc-Company Report
January 2010 £495
Newai Chemical Industrial Co. Ltd.-Company Report
January 2010 £495
Nippon Boehringer Ingelheim Co., Ltd.-Company Report
January 2010 £495
Nissui Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Nordic Bioscience a/s-Company Report
January 2010 £495
Nitto Denko Corporation-Company Report
January 2010 £495
NitroMed, Inc.-Company Report
January 2010 £495
New GPC Inc.-Company Report
January 2010 £495
Neurotech Pharmaceuticals, Inc.-Company Report
January 2010 £495
Neimeth International Pharmaceuticals PLC.-Company Report
January 2010 £495
NeED pharma-Company Report
January 2010 £495
Natren, Inc.-Company Report
January 2010 £495
NeoStrata Company, Inc.-Company Report
January 2010 £495
Neogenix Oncology Corporation-Company Report
January 2010 £495
Neumedicines Inc.-Company Report
January 2010 £495
Neopharm Ltd.-Company Report
January 2010 £495
Nordic Drugs AB-Company Report
January 2010 £495
Norma Hellas S.A.-Company Report
January 2010 £495
OPALIA Pharma-Company Report
January 2010 £495
NsGene A/S-Company Report
January 2010 £495
Novus Pharmaceuticals Ltd.-Company Report
January 2010 £495
ORALANCE PHARMA-Company Report
January 2010 £495
Olainfarm-Company Report
January 2010 £495
Oncolytics Biotech Inc-Company Report
January 2010 £495
Oman Pharmaceutical Products Co. L.L.C.-Company Report
January 2010 £495
Novozymes A/S-Company Report
January 2010 £495
Novogen Limited-Company Report
January 2010 £495
NovaLead Pharma Pvt. Ltd.-Company Report
January 2010 £495
NovImmune SA-Company Report
January 2010 £495
Northern Therapeutics Inc.-Company Report
January 2010 £495
Novartis Pharma K.K.-Company Report
January 2010 £495
Noven Pharmaceuticals, Inc.-Company Report
January 2010 £495
Novo Nordisk A/S-Company Report
January 2010 £495
Noventis s.r.o.-Company Report
January 2010 £495
Natrapharm Inc.-Company Report
January 2010 £495
National Enzyme Company-Company Report
January 2010 £495
Medpharma-Company Report
January 2010 £495
Medis laboratories-Company Report
January 2010 £495
Medipost Co., Ltd-Company Report
January 2010 £495
Meizler Biopharma S/A-Company Report
January 2010 £495
Meldex International Plc-Company Report
January 2010 £495
MicroDose Therapeutx, Inc. (formerly MicroDose Technologies, Inc.)-Company Report
January 2010 £495
MethylGene Inc-Company Report
January 2010 £495
Metabolic Pharmaceuticals Limited-Company Report
January 2010 £495
Medimetriks Pharmaceuticals, Inc.-Company Report
January 2010 £495
Medicure Inc.-Company Report
January 2010 £495
Medical Enzymes AG-Company Report
January 2010 £495
Medicago-Company Report
January 2010 £495
Medexus Inc.-Company Report
January 2010 £495
MedImmune, Inc. (formerly Cambridge Antibody Technology)-Company Report
January 2010 £495
Medical Futures Inc.-Company Report
January 2010 £495
Medicom International s.r.o.-Company Report
January 2010 £495
Medical Union Pharmaceuticals-Company Report
January 2010 £495
MOLOGEN AG-Company Report
January 2010 £495
M's Science Corporation-Company Report
January 2010 £495
NAL Pharmaceuticals Ltd-Company Report
January 2010 £495
Myriad Pharmaceuticals, Inc.-Company Report
January 2010 £495
Mymetics Corporation-Company Report
January 2010 £495
miRagen Therapeutics-Company Report
January 2010 £495
Nang Kuang Pharmaceutical Co., Ltd.-Company Report
January 2010 £495
Naprod Life Sciences Pvt. Ltd.-Company Report
January 2010 £495
NanoCarrier Co., Ltd.-Company Report
January 2010 £495
Mylan New Zealand Limited (formerly Pacific Pharmaceuticals Ltd)-Company Report
January 2010 £495
Multicare Pharmaceuticals Philippines Inc.-Company Report
January 2010 £495
Mimetogen Pharmaceuticals Inc.-Company Report
January 2010 £495
Migenix Inc-Company Report
January 2010 £495
Middle East Pharmaceutical and Chemical Industries & Medical Appliances Co.-Company Report
January 2010 £495
Mithridion, Inc-Company Report
January 2010 £495
Miwana AB-Company Report
January 2010 £495
Mt Cook Pharma-Company Report
January 2010 £495
Morphotek Inc.-Company Report
January 2010 £495
Oncovir, Inc-Company Report
January 2010 £495
One Pharma Company Inc.-Company Report
January 2010 £495
Proge Farm S.r.l.-Company Report
January 2010 £495
Profectus BioSciences, Inc.-Company Report
January 2010 £495
ProNAi Therapeutics, Inc.-Company Report
January 2010 £495
Progen Pharmaceuticals Ltd.-Company Report
January 2010 £495
Prollenium Medical Technologies Inc.-Company Report
January 2010 £495
Qualiphar NV-Company Report
January 2010 £495
PureTek Corporation-Company Report
January 2010 £495
Promed Group-Company Report
January 2010 £495
Prana Biotechnology Limited-Company Report
January 2010 £495
Portola Pharmaceuticals Inc.-Company Report
January 2010 £495
Plus India-Company Report
January 2010 £495
Plantacor, Inc-Company Report
January 2010 £495
Piramal Life Sciences Limited-Company Report
January 2010 £495
PRB Pharmaceuticals, Inc.-Company Report
January 2010 £495
PTC Therapeutics, Inc.-Company Report
January 2010 £495
Polichem S.A.-Company Report
January 2010 £495
Polfa Warszawa S.A.-Company Report
January 2010 £495
Quintessence Biosciences, Inc.-Company Report
January 2010 £495
RESprotect GmbH-Company Report
January 2010 £495
ratiopharm GmbH-Company Report
January 2010 £495
Riva Pharma, S.A.E.-Company Report
January 2010 £495
Riso Pharma Tech (RISO)-Company Report
January 2010 £495
R-Tech Ueno, Ltd.-Company Report
January 2010 £495
Ronak Healthcare-Company Report
January 2010 £495
SAF FERMION LIMITED-Company Report
January 2010 £495
Ruyan Group (Holdings) Limited-Company Report
January 2010 £495
Rising Pharmaceuticals, Inc-Company Report
January 2010 £495
Renata Limited-Company Report
January 2010 £495
Raptakos, Brett & Co.Ltd.-Company Report
January 2010 £495
Radiance Pharmaceutical (India) Private Limited-Company Report
January 2010 £495
RHEI Pharmaceuticals, Inc.-Company Report
January 2010 £495
Razak Laboratories Co.-Company Report
January 2010 £495
ReGen Therapeutics Plc-Company Report
January 2010 £495
Remington Pharmaceutical Industries (Pvt.) Ltd-Company Report
January 2010 £495
Reig Jofre Group-Company Report
January 2010 £495
Pico Pharmaceuticals-Company Report
January 2010 £495
Phytopharm Plc-Company Report
January 2010 £495
Parenteral Drug India Ltd.-Company Report
January 2010 £495
PanTheryx, Inc.-Company Report
January 2010 £495
PD Pharmaceuticals-Company Report
January 2010 £495
Parggon Laboratories Inc.-Company Report
January 2010 £495
Paviour Pharmaceuticals Pvt Ltd.-Company Report
January 2010 £495
Pepscan Holdings-Company Report
January 2010 £495
Pentech Pharmaceuticals, Inc-Company Report
January 2010 £495
Ozone Laboratories SRL-Company Report
January 2010 £495
Oy Verman Ab-Company Report
January 2010 £495
Orbus Pharma Inc-Company Report
January 2010 £495
Opsona Therapeutics-Company Report
January 2010 £495
OphthalmoPharma Ltd.-Company Report
January 2010 £495
Orchid Chemicals & Pharmaceuticals Limited-Company Report
January 2010 £495
Ortho Dermatologics (formerly Orthoneutrogena)-Company Report
January 2010 £495
Oscotec Inc.-Company Report
January 2010 £495
Oryzon genomics-Company Report
January 2010 £495
Pfizer Japan Inc.-Company Report
January 2010 £495
Phage Biotechnology Corp-Company Report
January 2010 £495
Phenomix Corporation-Company Report
January 2010 £495
Phebra-Company Report
January 2010 £495
Pharming Group NV-Company Report
January 2010 £495
Phico Therapeutics Ltd.-Company Report
January 2010 £495
Phosphagenics Limited-Company Report
January 2010 £495
Phytohealth Corporation-Company Report
January 2010 £495
Physica Pharma-Company Report
January 2010 £495
Pharmaxis Ltd-Company Report
January 2010 £495
Pharmatex Italia Srl-Company Report
January 2010 £495
Pharma Dynamics-Company Report
January 2010 £495
PharmEvo (Pvt.) Ltd.-Company Report
January 2010 £495
PHARMA INTERNATIONAL CO.-Company Report
January 2010 £495
Pharma Nord ApS-Company Report
January 2010 £495
PharmaBrand S.A.-Company Report
January 2010 £495
Pharmatec Pakistan (private) Limited-Company Report
January 2010 £495
PharmaGap Inc.-Company Report
January 2010 £495
BioCis Pharma Ltd.-Company Report
January 2010 £495
BioArctic Neuroscience AB-Company Report
January 2010 £495
Asia Pharmaceutical Industries-Company Report
January 2010 £495
Ascenta Therapeutics, Inc.-Company Report
January 2010 £495
Ascent Pharmahealth Limited (formerly Genepharm Australasia Limited)-Company Report
January 2010 £495
Asterion Ltd-Company Report
January 2010 £495
Astex Therapeutics-Company Report
January 2010 £495
Atley Pharmaceuticals, Inc-Company Report
January 2010 £495
Atlantic Healthcare Limited-Company Report
January 2010 £495
Astion Pharma A/S-Company Report
January 2010 £495
Ascend Therapeutics, Inc.-Company Report
January 2010 £495
Asahi Kasei Corporation-Company Report
January 2010 £495
Arpida Ltd.-Company Report
January 2010 £495
ArmaGen Technologies, Inc.-Company Report
January 2010 £495
Ark Therapeutics Group plc-Company Report
January 2010 £495
Arriva Pharmaceuticals, Inc-Company Report
January 2010 £495
Arrow Generics Ltd-Company Report
January 2010 £495
Arvind Remedies Ltd-Company Report
January 2010 £495
Arteriocyte Medical Systems, Inc.-Company Report
January 2010 £495
AtralCipan-Company Report
January 2010 £495
Attenuon, LLC-Company Report
January 2010 £495
Azur Pharma Limited-Company Report
January 2010 £495
Axcan Pharma Inc.-Company Report
January 2010 £495
Avontec GmbH-Company Report
January 2010 £495
B. Braun Melsungen AG-Company Report
January 2010 £495
B.F. Ascher & Co. Inc.-Company Report
January 2010 £495
BARAKAT Pharmaceutical Industries-Company Report
January 2010 £495
BAL PHARMA LTD.-Company Report
January 2010 £495
Avir Green Hills Biotechnology AG-Company Report
January 2010 £495
Avineuro Pharmaceuticals, Inc.-Company Report
January 2010 £495
Avanti Therapeutics-Company Report
January 2010 £495
Aurora Pharmaceuticals Pty Ltd.-Company Report
January 2010 £495
Aurobindo Pharma Ltd.-Company Report
January 2010 £495
Avera Pharmaceuticals, Inc.-Company Report
January 2010 £495
Avexa Limited-Company Report
January 2010 £495
Avila Therapeutics, Inc.-Company Report
January 2010 £495
Avidas Pharmaceuticals, LLC-Company Report
January 2010 £495
Arisyn Therapeutics, Inc.-Company Report
January 2010 £495
Aristopharma Ltd.-Company Report
January 2010 £495
Angion Biomedica Corp.-Company Report
January 2010 £495
Angioblast Systems, Inc.-Company Report
January 2010 £495
AngioLab, Inc.-Company Report
January 2010 £495
Anglo-French Drugs & Industries Ltd.-Company Report
January 2010 £495
Antibe Therapeutics Inc.-Company Report
January 2010 £495
Antisense Therapeutics Limited-Company Report
January 2010 £495
Antisense Pharma GmbH-Company Report
January 2010 £495
Antipodean Pharmaceuticals, Inc.-Company Report
January 2010 £495
AngioChem Inc.-Company Report
January 2010 £495
Angelini-Company Report
January 2010 £495
Amulet Pharmaceuticals, Inc.-Company Report
January 2010 £495
AmpliMed Corporation-Company Report
January 2010 £495
Amphastar Pharmaceuticals, Inc.-Company Report
January 2010 £495
Amura Holdings Ltd.-Company Report
January 2010 £495
AnGes MG, Inc.-Company Report
January 2010 £495
AndroScience Corporation-Company Report
January 2010 £495
Anacor Pharmaceuticals, Inc.-Company Report
January 2010 £495
Antyra, Inc.-Company Report
January 2010 £495
Anza Therapeutics, Inc.-Company Report
January 2010 £495
Argenta Discovery Ltd.-Company Report
January 2010 £495
Archimedes Pharma Limited-Company Report
January 2010 £495
Archer Pharmaceuticals, Inc.-Company Report
January 2010 £495
Argos Therapeutics, Inc., (formerly Merix Bioscience)-Company Report
January 2010 £495
Aridis Pharmaceuticals, LLC-Company Report
January 2010 £495
Aristo Pharmaceuticals Pvt. Ltd.-Company Report
January 2010 £495
Arisaph Pharmaceuticals, Inc.-Company Report
January 2010 £495
Archemix Corp.-Company Report
January 2010 £495
Aquinox Pharmaceuticals Inc.-Company Report
January 2010 £495
Apitope Technology (Bristol) Ltd-Company Report
January 2010 £495
Apipol-Farma Ltd-Company Report
January 2010 £495
Aphios Corporation-Company Report
January 2010 £495
Apogenix GmbH-Company Report
January 2010 £495
ApopLogic Pharmaceuticals, LLC-Company Report
January 2010 £495
Applied Genetic Technologies Corporation (AGTC)-Company Report
January 2010 £495
Apotex Inc.-Company Report
January 2010 £495
BCN Plc-Company Report
January 2010 £495
Bakhtar Bioshimi Co.-Company Report
January 2010 £495
Matrixx Initiatives Inc-Detailed Product Pipeline
January 2010 £495
Marshall Edwards Inc-Detailed Product Pipeline
January 2010 £495
Mannatech Inc-Detailed Product Pipeline
January 2010 £495
Medarex Inc-Detailed Product Pipeline
January 2010 £495
MediciNova Inc-Detailed Product Pipeline
January 2010 £495
Medivation Inc-Detailed Product Pipeline
January 2010 £495
Medistem, Inc.-Detailed Product Pipeline
January 2010 £495
Medicis Pharmaceutical Corp-Detailed Product Pipeline
January 2010 £495
MannKind Corp-Detailed Product Pipeline
January 2010 £495
Manhattan Pharmaceuticals Inc.-Detailed Product Pipeline
January 2010 £495
Xenoport Inc-Detailed Product Pipeline
January 2010 £495
XTL Biopharmaceuticals Ltd-Detailed Product Pipeline
January 2010 £495
XOMA Ltd-Detailed Product Pipeline
January 2010 £495
ZIOPHARM Oncology Inc-Detailed Product Pipeline
January 2010 £495
ZymoGenetics, Inc.-Detailed Product Pipeline
January 2010 £495
MDRNA, Inc.-Detailed Product Pipeline
January 2010 £495
Ardea Biosciences, Inc.-Detailed Product Pipeline
January 2010 £495
Merck & Co Inc-Detailed Product Pipeline
January 2010 £495
MicroIslet, Inc.-Detailed Product Pipeline
January 2010 £495
Neurobiological Technologies Inc-Detailed Product Pipeline
January 2010 £495
Neuro-Hitech Pharmaceuticals Inc-Detailed Product Pipeline
January 2010 £495
NeoPharm Inc-Detailed Product Pipeline
January 2010 £495
Neurocrine Biosciences Inc-Detailed Product Pipeline
January 2010 £495
Neurogen Corporation-Detailed Product Pipeline
January 2010 £495
NeurogesX, Inc.-Detailed Product Pipeline
January 2010 £495
Neurogenesis Inc-Detailed Product Pipeline
January 2010 £495